image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
c2348be8fabcae24b83cd514b35c196d61e0a99f3a635e1347cafcf3729c3a88.png | complex | <table><tr><td>Variables</td><td>No. of study (<i>n</i> = 28)</td><td>Coefficient (95% CI)</td><td><i>P</i> value</td></tr><tr><td colspan="4">Univariate meta-regression</td></tr><tr><td>Year of publication</td><td>28</td><td>0.03 (−0.03–0.08)</td><td>0.288</td></tr><tr><td>Male% in sample</td><td>28</td><t... | <table><tr><td>Variables</td><td>No. of study (n = 28)</td><td>Coefficient (95% CI)</td></tr><tr><td colspan="3">Univariate meta-regression</td></tr><tr><td>Year of publication</td><td>28</td><td>0.03 (−0.03–0.08)</td></tr><tr><td>Male% in sample</td><td>28</td><td>0.001 (−0.01–0.02)</td></tr><tr><td>Sample size</td><t... | <table><tr><td>P value</td></tr><tr><td>Univariate meta-regression</td></tr><tr><td>0.288</td></tr><tr><td>0.862</td></tr><tr><td>0.435</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.153</td></tr><tr><td>0.054</td></tr><tr><td></td></tr><tr><td>0.119</td></tr><tr><td>0.017</td></tr><tr><td></td></tr><tr><td></t... |
dd944cdd41844b4a29aab608fd145d6aecc254ff0b4801ec510801f30142c053.png | simple | <table><tr><td></td><td>Al</td><td>Cd</td><td>Cu</td><td>Fe</td><td>Pb</td><td>Zn</td><td>Na</td><td>Ca</td><td>K</td><td>Mg</td><td>DOC</td><td>PH =</td><td>Temp.</td></tr><tr><td>P1</td><td>NS</td><td>*(0.89)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.80)</td><... | <table><tr><td></td><td>Al</td><td>Cd</td><td>Cu</td><td>Fe</td><td>Pb</td><td>Zn</td><td>Na</td><td>Ca</td></tr><tr><td>P1</td><td>NS</td><td>*(0.89)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>P1.1</td><td>NS</td><td>*(0.82)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS... | <table><tr><td>K</td><td>Mg</td><td>DOC</td><td>PH =</td><td>Temp.</td></tr><tr><td>NS</td><td>NS</td><td>*(0.80)</td><td>*(0.85)</td><td>NS</td></tr><tr><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>NS</td><td>NS</td><td>*(0.80)</td><td>*(0.86)</td><td>NS</td></tr><tr><td>NS</td><td>NS</td><td>NS... |
c318e550fe5305232a697eb7c216ffd0dd63855bb5471993294f8ea05a2ccfd3.png | simple | <table><tr><td> </td><td>3 hours</td><td>24 hours</td><td>7 days</td></tr><tr><td>Pulpdent</td><td>6.3-7.2</td><td>7.1-8.2</td><td>7.4-7.9</td></tr><tr><td>Dycal</td><td>5.8-7.6</td><td>7.2-7.8</td><td>7.4-7.8</td></tr><tr><td>ProRoot MTA</td><td>6.2-7.3</td><td>7.1-7.5</td><td>7.5-7.8</td></tr><tr><td>Negative control... | <table><tr><td></td><td>3 hours</td><td>24 hours</td><td>7 days</td></tr><tr><td>Pulpdent</td><td>6.3-7.2</td><td>7.1-8.2</td><td>7.4-7.9</td></tr></table> | <table><tr><td></td><td>3 hours</td><td>24 hours</td><td>7 days</td></tr><tr><td>Dycal</td><td>5.8-7.6</td><td>7.2-7.8</td><td>7.4-7.8</td></tr><tr><td>ProRoot MTA</td><td>6.2-7.3</td><td>7.1-7.5</td><td>7.5-7.8</td></tr><tr><td>Negative control</td><td>5.7-7.2</td><td>6.0-7.6</td><td>6.8-7.7</td></tr><tr><td>Positive ... |
5aef4a9b2225fbf16c7b75afa92028d5e33fb6468b4a7cff3e91798dd04e08a2.png | simple | <table><tr><td></td><td>BMI</td><td>Macrosomia (<i>n</i> =700)</td><td>Control (<i>n</i> =5137)</td><td>OR (95%CI)</td><td><i>P</i></td></tr><tr><td>Male</td><td>Normal</td><td>259(60.66%)</td><td>1,838(69.99%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>99(23.19%)</td><td>459(17.52%)</td><td>1.53(... | <table><tr><td></td><td>BMI</td><td>Macrosomia (n =700)</td><td>Control (n =5137)</td><td>OR (95%CI)</td><td>P</td></tr><tr><td>Male</td><td>Normal</td><td>259(60.66%)</td><td>1,838(69.99%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>99(23.19%)</td><td>459(17.52%)</td><td>1.53(1.19-1.97)</td><td>0.... | <table><tr><td></td><td>Obesity</td><td>69(16.15%)</td><td>328(12.49%)</td><td>1.49(1.14-1.99)</td><td>0.007</td></tr><tr><td>Female</td><td>Normal</td><td>183(67.03%)</td><td>1,873(74.56%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>58(21.24%)</td><td>408(16.24%)</td><td>1.45(1.06-1.99)</td><td>0.... |
954a163868b0946929d7949d25f6691a80a30afcdbe4234bc5437b366a9214e6.png | simple | <table><tr><td>Group</td><td>Material</td><td>Contrast</td><td>Region of main effect</td><td>Comparison with controls (increased/decreased, location)</td><td>Correlation with memory performance (location, correlating measure)</td></tr><tr><td>Controls</td><td>Words</td><td>Remembered > forgotten</td><td>Left HC</td>... | <table><tr><td>Group</td><td>Material</td><td>Contrast</td><td>Region of main effect</td><td>Comparison with controls (increased/decreased, location)</td><td>Correlation with memory performance (location, correlating measure)</td></tr><tr><td>Controls</td><td>Words</td><td>Remembered > forgotten</td><td>Left HC</td><td... | <table><tr><td>Group</td><td>Material</td><td>Contrast</td><td>Region of main effect</td><td>Comparison with controls (increased/decreased, location)</td><td>Correlation with memory performance (location, correlating measure)</td></tr><tr><td></td><td>Pictures</td><td></td><td>Right PHG</td><td>Reduced, Left HC</td><td... |
685294ff796045f4976ec8e5194208cbe3518b98272c7b5d06856c69c84eaea6.png | complex | <table><tr><td rowspan="3"></td><td colspan="6">Bivariate associations (<i>n</i> = 3438)</td><td colspan="2">Adjusted odds ratios (<i>n</i> = 3293)</td></tr><tr><td colspan="2">Increased = No</td><td colspan="2">Increased = Yes</td><td>OR</td><td>95% CI<sup>1</sup></td><td>AOR<sup>a</sup></td><td>95% CI<sup>1</sup></td... | <table><tr><td rowspan="3"></td><td colspan="6">Bivariate associations (n = 3438)</td><td colspan="2">Adjusted odds ratios (n = 3293)</td></tr><tr><td colspan="2">Increased = No</td><td colspan="2">Increased = Yes</td><td>OR</td><td>95% CI1</td><td>AORa</td><td>95% CI1</td></tr><tr><td>n</td><td>(%)</td><td>n</td><td>(... | <table><tr><td colspan="9">Site level</td></tr><tr><td>Primary</td><td>1932</td><td>78%</td><td>552</td><td>22%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td>Secondary</td><td>594</td><td>73%</td><td>218</td><td>27%</td><td>1.28</td><td>(1.07, 1.54)**</td><td>1.20</td><td>(0.95, 1.51)</td></tr><tr><td>Tert... |
0a7001bc46bd0f3a8bb0c22fe1875cf7e578d22102cc403097afa1d0e1550ae2.png | complex | <table><tr><td rowspan="2">Culture</td><td colspan="9">MIC mode (μg/ml)<sup>a</sup></td></tr><tr><td>Carb</td><td>Cpz</td><td>Gent<sup>b</sup></td><td>Kan<sup>b</sup></td><td>Levo</td><td>Nor</td><td>Rif</td><td>Tet</td><td>Vanc</td></tr><tr><td><i>M. smegmatis</i></td><td></td><td></td><td></td><td></td><td></td>... | <table><tr><td rowspan="2">Culture</td><td colspan="9">MIC mode (μg/ml)a</td></tr><tr><td>Carb</td><td>Cpz</td><td>Gentb</td><td>Kanb</td><td>Levo</td><td>Nor</td><td>Rif</td><td>Tet</td><td>Vanc</td></tr><tr><td>M. smegmatis</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr>... | <table><tr><td rowspan="2">Culture</td><td colspan="9">MIC mode (μg/ml)a</td></tr><tr><td>Carb</td><td>Cpz</td><td>Gentb</td><td>Kanb</td><td>Levo</td><td>Nor</td><td>Rif</td><td>Tet</td><td>Vanc</td></tr><tr><td>pH 6.6 + DNP</td><td></td><td>50</td><td></td><td>2.0</td><td></td><td>2.0</td><td>13</td><td></td><td></td... |
6e5420cae87782003a8f0aac01c0ffbbf576abf519412a28c510fa5ce65e73d7.png | simple | <table><tr><td>Solution Set</td><td>Health Status Level</td><td>Health Description</td><td>Maintenance Level</td></tr><tr><td><i>A</i><sub>1</sub></td><td>Health (<i>HS</i>)</td><td>healthy condition</td><td>No maintenance</td></tr><tr><td><i>A</i><sub>2</sub></td><td>Subhealth (<i>SHS</i>)</td><td>normal range</td><td... | <table><tr><td>Solution Set</td><td>Health Status Level</td><td>Health Description</td><td>Maintenance Level</td></tr></table> | <table><tr><td>A1</td><td>Health (HS)</td><td>healthy condition</td><td>No maintenance</td></tr><tr><td>A2</td><td>Subhealth (SHS)</td><td>normal range</td><td>Preventive maintenance</td></tr><tr><td>A3</td><td>failure edge (FES)</td><td>fault edge</td><td>Corrective maintenance</td></tr><tr><td>A4</td><td>Failure (FS)... |
3e0dd84e56d784cbef967230b34e1d2244b0174ec1953e02ec16c349e6db938b.png | simple | <table><tr><td>Reference</td><td>Study</td><td># Cases</td><td># Controls</td><td>Outcomes</td><td>Comment</td></tr><tr><td>[214]</td><td>Nurses' Health Study</td><td>3,483</td><td></td><td>↓folate intake + alcohol = ↑risk of breast cancer (OR = 0.55, P-trend = 0.001)</td><td>Folate intake not associated wi... | <table><tr><td>Reference</td><td>Study</td><td># Cases</td><td># Controls</td><td>Outcomes</td><td>Comment</td></tr></table> | <table><tr><td>[214]</td><td>Nurses' Health Study</td><td>3,483</td><td></td><td>↓folate intake + alcohol = ↑risk of breast cancer (OR = 0.55, P-trend = 0.001)</td><td>Folate intake not associated with overall risk of breast cancer</td></tr><tr><td>[215]</td><td>Canadian National Breast Screening Study</td><td>1,336</t... |
d26a996ead4a9f860b0ac2117a4d0df673f38859470cc69741456a8002cd1348.png | simple | <table><tr><td></td><td>Formulations</td><td>Crystalline Phase (wt%)</td><td>Amorphous Phase (wt%)</td></tr><tr><td></td><td>Pure Ca/Mg-rich glass</td><td>66</td><td>34</td></tr><tr><td>1</td><td>H62C + fillers</td><td>88</td><td>12</td></tr><tr><td>2</td><td>H62C + fillers + 10 wt% glass</td><td>98</td><td>2</td></tr>... | <table><tr><td></td><td>Formulations</td><td>Crystalline Phase (wt%)</td><td>Amorphous Phase (wt%)</td></tr><tr><td></td><td>Pure Ca/Mg-rich glass</td><td>66</td><td>34</td></tr></table> | <table><tr><td>1</td><td>H62C + fillers</td><td>88</td><td>12</td></tr><tr><td>2</td><td>H62C + fillers + 10 wt% glass</td><td>98</td><td>2</td></tr><tr><td>3</td><td>MK + fillers</td><td>92</td><td>8</td></tr><tr><td>4</td><td>MK + fillers + 10 wt% glass</td><td>96</td><td>4</td></tr></table> |
ed09eb3deb26865c3ec6a9bc0546460dedaf845f5cc89defc350ad610ab3e532.png | complex | <table><tr><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence ≥3%</td><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence ≥1.5%</td></tr><tr><td>Characteristics</td><td>Estimates</td><td>Characteristics</td><t... | <table><tr><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence ≥3%</td><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence ≥1.5%</td></tr><tr><td>Characteristics</td><td>Estimates</td><td>Characteristics</td><td>Estimates<... | <table><tr><td>• 15–19 years old• 20–24 years old</td><td>000</td><td>rs old</td><td>ion</td></tr><tr><td colspan="2">Countries: Kenya, Lesotho, Mozambique, South Africa, Swaziland.</td><td colspan="2">Countries: Kenya, Lesotho, Mozambique, South Africa, Swaziland, Zimbabwe and Uganda.</td></tr></table> |
cadb149b967cfbdb22d7012409450a19750afa2669b82358ec9e96f2668dc1cb.png | complex | <table><tr><td>Groups</td><td>Specific Diseases (ICD-10 Coding) [Number of GPs Mentioning It]</td></tr><tr><td rowspan="2">ICD-10 E86 Volume depletion/ E87 Other disorders of fluid, electrolyte and acid-base balance [22/24]</td><td>E86 Volume depletion OR T67.3 Heat exhaustion due to water depletion [18]</td></tr><tr><... | <table><tr><td>Groups</td><td>Specific Diseases (ICD-10 Coding) [Number of GPs Mentioning It]</td></tr><tr><td rowspan="2">ICD-10 E86 Volume depletion/ E87 Other disorders of fluid, electrolyte and acid-base balance [22/24]</td><td>E86 Volume depletion OR T67.3 Heat exhaustion due to water depletion [18]</td></tr><tr><... | <table><tr><td>Groups</td><td>Specific Diseases (ICD-10 Coding) [Number of GPs Mentioning It]</td></tr><tr><td rowspan="3">ory diseases, ICD10-I00-I99 [15/24]</td><td>n</td></tr><tr><td>I95 Hypotension [4]</td></tr><tr><td>Other [3]: I74 Arterial embolism and thrombosis [1], I64 Stroke, not specified as hemorrhage or i... |
d12c007adbb33e8dcbb12d51af149017e3c865233bc9d517c7413855a4448cd3.png | complex | <table><tr><td>Question</td><td><i>n</i> (%)</td></tr><tr><td colspan="2">Do customers talk about experiences of trying to quit smoking?</td></tr><tr><td> Yes many do</td><td>30 (73)</td></tr><tr><td> Yes some do</td><td>9 (22)</td></tr><tr><td> No</td><td>1 (2)</td></tr><tr><td> No response</td><td>1 (2)</td></tr><tr>... | <table><tr><td>Question</td><td>n (%)</td></tr><tr><td colspan="2">Do customers talk about experiences of trying to quit smoking?</td></tr><tr><td>Yes many do</td><td>30 (73)</td></tr><tr><td>Yes some do</td><td>9 (22)</td></tr><tr><td>No</td><td>1 (2)</td></tr><tr><td>No response</td><td>1 (2)</td></tr><tr><td colspan... | <table><tr><td>Question</td><td>n (%)</td></tr><tr><td colspan="2">What kind of information do you give to customers? (multiple responses permitted)</td></tr><tr><td>Product information</td><td>38 (93)</td></tr><tr><td>Smoking cessation advice</td><td>17 (41)</td></tr><tr><td>Information how to cut down regular cigaret... |
10015d547525ade978c4af77e398bca20d172c9a6fe2374f3dc8c30d3c87eb9e.png | simple | <table><tr><td>Characteristics of patients</td><td>100</td></tr><tr><td>Phototype</td><td> </td></tr><tr><td>I</td><td>0 (0%)</td></tr><tr><td>II</td><td>72 (72%)</td></tr><tr><td>III</td><td>28 (28%)</td></tr><tr><td>IV</td><td>0 (0%)</td></tr><tr><td>V</td><td>0 (0%)</td></tr><tr><td>Skin hydration</td><td> </td></tr... | <table><tr><td>Characteristics of patients</td><td>100</td></tr><tr><td>Phototype</td><td></td></tr><tr><td>I</td><td>0 (0%)</td></tr><tr><td>I</td><td>72 </td></tr></table> | <table><tr><td>Characteristics of patients</td><td>100</td></tr><tr><td>I</td><td>(72%)</td></tr><tr><td>III</td><td>28 (28%)</td></tr><tr><td>IV</td><td>0 (0%)</td></tr><tr><td>V</td><td>0 (0%)</td></tr><tr><td>Skin hydration</td><td></td></tr><tr><td>dry skin</td><td>56 (56%)</td></tr><tr><td>normal skin</td><td>10 (... |
9d3323a6d0549482da837403adc88b5f94fa1425b895f2058709ae46772cc02d.png | complex | <table><tr><td></td><td colspan="2">Rate ratio (95% CI<sup>a</sup>)</td><td>Intervention effect ratio<sup>b</sup></td></tr><tr><td></td><td colspan="2">(intervention period relative to baseline)</td><td>(95% CI<sup>a</sup>)</td></tr><tr><td>Outcome variable</td><td>Intervention</td><td>Control</td><td></td></tr><tr><td... | <table><tr><td></td><td colspan="2">Rate ratio (95% CIa)</td><td>Intervention effect ratiob</td></tr><tr><td></td><td colspan="2">(intervention period relative to baseline)</td><td>(95% CIa)</td></tr><tr><td>Outcome variable</td><td>Intervention</td><td>Control</td><td></td></tr><tr><td>ISH presentations and self-infli... | <table><tr><td></td><td colspan="2">Rate ratio (95% CIa)</td><td>Intervention effect ratiob</td></tr><tr><td></td><td colspan="2">(intervention period relative to baseline)</td><td>(95% CIa)</td></tr><tr><td>Outcome variable</td><td>Intervention</td><td>Control</td><td></td></tr><tr><td>ISH presentations only</td><td>0... |
fde9cf400773a15f5ece6e735ddf31d8f5c7e96422d41137807e520cbebbfa54.png | simple | <table><tr><td>Sample</td><td>Conc.(μg/ml)</td><td>No of brine shrimps taken</td><td>No of brine shrimps killed</td><td>LC<sub>50 </sub>(μg/ml)</td></tr><tr><td></td><td>1000</td><td>10</td><td>10 ± 0</td><td></td></tr><tr><td></td><td>100</td><td>10</td><td>10 ± 0</td><td></td></tr><tr><td></td><td... | <table><tr><td>Sample</td><td>Conc.(μg/ml)</td><td>No of brine shrimps taken</td><td>No of brine shrimps killed</td><td>LC50 (μg/ml)</td></tr><tr><td></td><td>1000</td><td>10</td><td>10 ± 0</td><td></td></tr><tr><td></td><td>100</td><td>10</td><td>10 ± 0</td><td></td></tr><tr><td></td><td>10</td><td>10</td><td>10 ± 0</... | <table><tr><td></td><td>100</td><td>10</td><td>10 ± 0</td><td></td></tr><tr><td></td><td>10</td><td>10</td><td>9.8 ± 0.76</td><td></td></tr><tr><td>CST</td><td>7.5</td><td>10</td><td>7 ± 0.5</td><td>5.23 ± 0.34</td></tr><tr><td></td><td>5</td><td>10</td><td>5 ± 0.5</td><td></td></tr><tr><td></td><td>2.5</td><td>10</td>... |
109ca5a012ed58355f8165eed4846417cbab537b86d8f9bd213d543aba170f04.png | simple | <table><tr><td>Responses (verbatim)</td><td>Number of health workers (n=10)</td><td>Percentage (%)</td></tr><tr><td>We usually ask if they had finished the treatment</td><td>1</td><td>10</td></tr><tr><td>When they come we check the container, most have finishedbut others did not finish due to nausea and vomiting. Those... | <table><tr><td>Responses (verbatim)</td><td>Number of health workers (n=10)</td></tr><tr><td>We usually ask if they had finished the treatment</td><td>1</td></tr><tr><td>When they come we check the container, most have finishedbut others did not finish due to nausea and vomiting. Thosewho did not finish we educate them... | <table><tr><td>Percentage (%)</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr><tr><td>10</td></tr></table> |
4818504169a449d071be3077b00a15f4b848aa83a5ed98cd5b888e2d6463ab79.png | complex | <table><tr><td colspan="2">Phantom configuration</td><td>True sphere/background ratio</td><td colspan="3">SPECT alone</td><td colspan="3">SPECT-CT</td></tr><tr><td colspan="2"> </td><td> </td><td>Isocontour (%)</td><td>Measured volume (cm<sup>3</sup>)</td><td>Error (%)</td><td>Isocontour (%)</td><td>Measured volume (cm... | <table><tr><td colspan="2">Phantom configuration</td><td>True sphere/background ratio</td><td colspan="3">SPECT alone</td><td colspan="3">SPECT-CT</td></tr><tr><td colspan="2"></td><td></td><td>Isocontour (%)</td><td>Measured volume (cm3)</td><td>Error (%)</td><td>Isocontour (%)</td><td>Measured volume (cm3)</td><td>Er... | <table><tr><td rowspan="5">18,5 MBq/sphere</td><td>Cylinder 1</td><td>—</td><td>1%</td><td>7087</td><td>5,52</td><td>2%</td><td>6521</td><td>−2,90</td></tr><tr><td>Sphere 1</td><td>2.8</td><td>31%</td><td>207</td><td>276,36</td><td>48%</td><td>57,2</td><td>4,00</td></tr><tr><td>Sphere 2</td><td>7.6</td><td>13%</td><td>... |
51f5aa6588e8e8b1a683b3d28d0d434053c56bd54caab6796c8fe0586dcb9ea6.png | complex | <table><tr><td rowspan="2">Clinical parameters</td><td>Total</td><td>Male patients</td><td>Female patients</td><td><i>p</i>-value</td></tr><tr><td>Median(25th–75th)</td><td>Median(25th–75th)</td><td>Median(25th–75th)</td><td></td></tr><tr><td>Age(years)</td><td>47.5 ± 11.94</td><td>50.19 ± 1... | <table><tr><td rowspan="2">Clinical parameters</td><td>Total</td><td>Male patients</td><td>Female patients</td><td>p-value</td></tr><tr><td>Median(25th–75th)</td><td>Median(25th–75th)</td><td>Median(25th–75th)</td><td></td></tr><tr><td>Age(years)</td><td>47.5 ± 11.94</td><td>50.19 ± 12.43</td><td>45.04 ± 11.17</td><td>... | <table><tr><td>g/dl)</td><td>–4.18)</td><td>4)</td><td></td><td>9</td></tr><tr><td>Urine volume(ml/24 h)</td><td>1350(900–2237.5)</td><td>1650(950–2237.5)</td><td>1150(825–2250)</td><td>0.39</td></tr><tr><td>Urine creatinine(mg/24 h)</td><td>1227(949.5–1624)</td><td>1538(1150–1789.5)</td><td>1011(725–1273.5)</td><td>0.... |
7792ca7fd46dcc08c4014c7ba12b3ddcd250d6a6824dc9df90daacc25746aaa0.png | simple | <table><tr><td>Instruments</td><td>Categories</td><td>Variables</td></tr><tr><td>Baseline questionnaire</td><td>Demographic characteristics</td><td>Age; Sex; Nationality; Education; Occupation; Marriage; Family income of last year; Health insurance, etc.</td></tr><tr><td></td><td>Family history</td><td>Liver, renal and... | <table><tr><td>Instruments</td><td>Categories</td><td>Variables</td></tr><tr><td>Baseline questionnaire</td><td>Demographic characteristics</td><td>Age; Sex; Nationality; Education; Occupation; Marriage; Family income of last year; Health insurance, etc.</td></tr><tr><td></td><td>Family history</td><td>Liver, renal and... | <table><tr><td>Categories</td><td>Variables</td></tr><tr><td>Other drugs</td><td>Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of other drugs used during the anti-TB therapy, for example, antihypertensive drugs, hypoglycaemic drugs, etc.</td></tr></table> |
4886d12e7a47871f56c4593213bd01e1787097b607a9702317acdc69a5749b2b.png | complex | <table><tr><td colspan="3">model</td><td colspan="2">traditional method</td></tr><tr><td></td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td></tr><tr><td>≤ T2</td><td>84.1</td><td>96.1</td><td>41.3</td><td>96.3</td></tr><tr><td>T3</td><td>81.8</td><td>89.7</td><td>... | <table><tr><td colspan="2">model</td></tr><tr><td></td><td>Sensitivity (%)</td></tr><tr><td>≤ T2</td><td>84.1</td></tr><tr><td>T3</td><td>81.8</td></tr><tr><td>T4</td><td>95.2</td></tr></table> | <table><tr><td>model</td><td colspan="2">traditional method</td></tr><tr><td>Specificity (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td></tr><tr><td>96.1</td><td>41.3</td><td>96.3</td></tr><tr><td>89.7</td><td>27.3</td><td>69</td></tr><tr><td>94.6</td><td>85.7</td><td>61.2</td></tr></table> |
9f0a4568cc3ce8df77ff277082048411da130e8a3afbe14b0b19f282966f025b.png | complex | <table><tr><td></td><td></td><td colspan="3">Within population a</td><td colspan="3">Between populations b</td></tr><tr><td>Chr</td><td>Site</td><td>Pop. c</td><td><i>π</i></td><td>Tajima’s <i>D</i></td><td>MAF</td><td><i>F<sup>U</sup></i></td><td><i>F<sup>W</sup></i></td></tr><tr><td>A</td><td>0-fold</td><t... | <table><tr><td></td><td></td><td colspan="3">Within population a</td><td colspan="3">Between populations b</td></tr><tr><td>Chr</td><td>Site</td><td>Pop. c</td><td>π</td><td>Tajima’s D</td><td>MAF</td><td>FU</td><td>FW</td></tr><tr><td>A</td><td>0-fold</td><td>RG</td><td>0.0012</td><td>−0.8397</td><td>0.1222</td><td>0.... | <table><tr><td></td><td></td><td colspan="3">Within population a</td><td colspan="3">Between populations b</td></tr><tr><td>Chr</td><td>Site</td><td>Pop. c</td><td>π</td><td>Tajima’s D</td><td>MAF</td><td>FU</td><td>FW</td></tr><tr><td></td><td></td><td>FR</td><td>0.0119</td><td>0.1116</td><td></td><td></td><td></td></... |
166d86de823b4a70dc4bdb30de3040a4bbb209dab013442c014dddaab581e442.png | complex | <table><tr><td>Age</td><td>Sex</td><td>Start [g]</td><td>Final eu [g]</td><td>Final hyper [g]</td><td>Final hypo [g]</td></tr><tr><td rowspan="2">Adult</td><td>Males</td><td>40.2 ± 5.0</td><td>45.8 ± 3.7 **</td><td>40.1 ± 4.1</td><td>35.6 ± 2.0 *</td></tr><tr><td>Females</td><td>28.0 ± 1.4<sup>... | <table><tr><td>Age</td><td>Sex</td><td>Start [g]</td><td>Final eu [g]</td><td>Final hyper [g]</td><td>Final hypo [g]</td></tr><tr><td>Adult</td><td>Males</td><td>40.2 ± 5.0</td><td>45.8 ± 3.7 **</td><td>40.1 ± 4.1</td><td>35.6 ± 2.0 *</td></tr></table> | <table><tr><td>Age</td><td>Sex</td><td>Start [g]</td><td>Final eu [g]</td><td>Final hyper [g]</td><td>Final hypo [g]</td></tr><tr><td>Adult</td><td>Females</td><td>28.0 ± 1.4††††</td><td>30.5 ± 3.1††</td><td>34.3 ± 2.2 ***</td><td>27.0 ± 1.6</td></tr><tr><td rowspan="2">Old</td><td>Males</td><td>39.0 ± 5.2</td><td>41.3... |
78a336a6d156c6f81dd7866e01275c7f22eddc591fa7c720ea295f7fd6a8ce40.png | complex | <table><tr><td>Variables</td><td>Frequency (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>363 (58.8)</td></tr><tr><td> Female</td><td>254 (41.2)</td></tr><tr><td colspan="2">Age (years, <i>n</i> = 569)</td></tr><tr><td> 15–19</td><td>75 (13.2)</td></tr><tr><td> 20–24</td><td>451 (79.3)<... | <table><tr><td>Variables</td><td>Frequency (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Male</td><td>363 (58.8)</td></tr><tr><td>Female</td><td>254 (41.2)</td></tr><tr><td colspan="2">Age (years, n = 569)</td></tr><tr><td>15–19</td><td>75 (13.2)</td></tr><tr><td>20–24</td><td>451 (79.3)</td></tr><tr><td>≥ 25</... | <table><tr><td colspan="2">Income Category (in birr)</td></tr><tr><td>≤ 500</td><td>306 (68.8)</td></tr><tr><td>501–1000</td><td>92 (20.7)</td></tr><tr><td>≥ 1001</td><td>47 (10.6)</td></tr><tr><td colspan="2">Mother’s Educational Status</td></tr><tr><td>Not Educated</td><td>277 (44.9)</td></tr><tr><td>Primary school</... |
8322d9ac2aa619f6922c94006f51d08a1ffa538c33e3d9d89e2f0d0e7a5f0a61.png | complex | <table><tr><td>Group</td><td>N</td><td colspan="2">Pain intensity</td><td colspan="2">Facial Swelling</td><td colspan="2">Mouth Opening</td></tr><tr><td></td><td></td><td>D1</td><td>D2</td><td>D1</td><td>D2</td><td>D1</td><td>D2</td></tr><tr><td>Group I</td><td>50</td><td>0.62 ± 0.6*</td><td>0.5 ± 0.51*</td><... | <table><tr><td>Group</td><td>N</td><td>Pain intensity</td></tr><tr><td></td><td></td><td>D1</td></tr><tr><td>Group I</td><td>50</td><td>0.62 ± 0.6*</td></tr><tr><td>Group II</td><td>50</td><td>1.64 ± 0.9*</td></tr></table> | <table><tr><td>Pain intensity</td><td colspan="2">Facial Swelling</td><td colspan="2">Mouth Opening</td></tr><tr><td>D2</td><td>D1</td><td>D2</td><td>D1</td><td>D2</td></tr><tr><td>0.5 ± 0.51*</td><td>30.9 ± 1.6*</td><td>31.0 ± 1.58*</td><td>36.0 ± 11.2</td><td>38.1 ± 10.05</td></tr><tr><td>1.3 ± 0.62*</td><td>31.7 ± 1... |
83e3248167d11f2b24b5f7072efae6acdb3543dda2fda4c1b16503788dbe75ba.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Population(CT <i>n</i> = 327, HPV <i>n</i> = 324)</td><td colspan="3">Vaccinees(CT <i>n</i> = 248, HPV <i>n</i> = 245)</td><td colspan="3">Non vaccinees(CT <i>n</i> = 77, HPV n = 77)</td><td rowspan="2">p-value</td></tr><tr><td>n</td><td>pr</td><td>sd</td><td>n</td><td>pr... | <table><tr><td></td><td colspan="3">Popul</td><td colspan="3">Vaccinees(CT n = 24</td><td colspan="3">Non vaccine</td><td>p-valu</td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="3">ation(CT n = 327, HPV n = 324)</td><td colspan="3">8, HPV n = 245)</td><td colspan="3">es(CT n = 77, HPV n = 77)</td><td rowspan="2">e</td></tr><tr><td>n</td><td>pr</td><td>sd</td><td>n</td><td>pr</td><td>sd</td><td>n</td><td>pr</td><td>sd</td></tr><tr><td>CT</td><td>15</... |
0c4e2bfb773edfd2bac46eccb3c1c5168d682e3a80373819c6f98cf87f741a34.png | complex | <table><tr><td>SIMD quintile & domain</td><td>Mean score out of 10 & (SD)</td><td>Developmentally vulnerable</td><td>Developmentally at risk</td><td colspan="2">On track</td></tr><tr><td> </td><td> </td><td>In the lowest 10%</td><td>Between the 10th and the 25th percentile</td><td>Between the 25th and 50th perc... | <table><tr><td>SIMD quintile & domain</td><td>Mean score out of 10 & (SD)</td><td>Developmentally vulnerable</td><td>Developmentally at risk</td><td colspan="2">On track</td></tr><tr><td></td><td></td><td>In the lowest 10%</td><td>Between the 10th and the 25th percentile</td><td>Between the 25th and 50th percentile</td... | <table><tr><td>SIMD quintile & domain</td><td>Mean score out of 10 & (SD)</td><td>Developmentally vulnerable</td><td>Developmentally at risk</td><td colspan="2">On track</td></tr><tr><td></td><td></td><td>In the lowest 10%</td><td>Between the 10th and the 25th percentile</td><td>Between the 25th and 50th percentile</td... |
b6df4ee5d1e9b2ef1d7ae214a9ff72ded721e89e6e80c753b8bced7e7cbeff91.png | complex | <table><tr><td></td><td></td><td></td><td colspan="7">Age group</td></tr><tr><td></td><td>Label reason for encounter</td><td>Total N (%)</td><td>0–4 N (%)</td><td>5–14 N (%)</td><td>15–24 N (%)</td><td>25–44 N (%)</td><td>45–64 N (%)</td><td>65–74 N (%)</td><td>75+ N (%)</td></tr><tr... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>9</td></tr><tr><td>10</td></tr></table> | <table><tr><td></td><td></td><td colspan="7">Age group</td></tr><tr><td>Label reason for encounter</td><td>Total N (%)</td><td>0–4 N (%)</td><td>5–14 N (%)</td><td>15–24 N (%)</td><td>25–44 N (%)</td><td>45–64 N (%)</td><td>65–74 N (%)</td><td>75+ N (%)</td></tr><tr><td>Symptoms or complaints of sinus (including pain)a... |
5c18f0eacb373e8a86edc05703436f37a050a40f9804450d0a614d81f8cb16e0.png | complex | <table><tr><td>Fixed effects</td><td>Coefficient value</td><td>Standard error</td><td>Degrees of freedom</td><td><i>P</i>-value<sup>a</sup></td></tr><tr><td>Intercept</td><td>44.917</td><td>0.776</td><td>57</td><td><.0001</td></tr><tr><td>D530c vs. D-SPECT</td><td>−26.300</td><td>1.049</td><td>12</td><td><.... | <table><tr><td>Fixed effects</td><td>Coefficient value</td><td>Standard error</td><td>Degrees of freedom</td><td>P-valuea</td></tr><tr><td>Intercept</td><td>44.917</td><td>0.776</td><td>57</td><td><.0001</td></tr><tr><td>D530c vs. D-SPECT</td><td>−26.300</td><td>1.049</td><td>12</td><td><.0001</td></tr><tr><td>A-SPECT ... | <table><tr><td>Fixed effects</td><td>Coefficient value</td><td>Standard error</td><td>Degrees of freedom</td><td>P-valuea</td></tr><tr><td>he D-SPECT</td><td></td><td>.072</td><td>7</td><td>001</td></tr><tr><td>Slope for the D530c</td><td>0.277</td><td>0.043</td><td>57</td><td><.0001</td></tr><tr><td>Slope for the A-SP... |
ae0daed60ee0841112989cbad65fc06877266d67d324b17a0ab493cfab0a7aee.png | complex | <table><tr><td>Combination*</td><td>Patients</td><td>Controls</td><td><i>P</i></td><td>OR; 95% CI; <i>P</i></td><td>OR; 95% CI; <i>P</i>**</td></tr><tr><td>Men</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T-A-G-C</td><td>45.03%</td><td>44.23%</td><td>0.807</td><td colspan="2">Reference group</td></tr><... | <table><tr><td>Combination*</td><td>Patients</td><td>Controls</td><td>P</td><td>OR; 95% CI; P</td><td>OR; 95% CI; P**</td></tr><tr><td>Men</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T-A-G-C</td><td>45.03%</td><td>44.23%</td><td>0.807</td><td colspan="2">Reference group</td></tr><tr><td>G-G-G-C</td><t... | <table><tr><td>Combination*</td><td>Patients</td><td>Controls</td><td>P</td><td>OR; 95% CI; P</td><td>OR; 95% CI; P**</td></tr><tr><td>T-A-G-T</td><td>1.24%</td><td>5.21%</td><td>0.001</td><td>0.34; 0.15–0.77; 0.010</td><td>0.33; 0.15–0.76; 0.010</td></tr></table> |
5a88d4067919a456a9fb4b714a0b86ae1f8d83eb6752415aafd16c3bc4cc1bb0.png | complex | <table><tr><td> </td><td>Continuous level (1/day)</td><td>p-value</td><td colspan="4">Level of soy consumption<sup>b</sup></td></tr><tr><td> </td><td> </td><td> </td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>Total soy</td><td> </td><td> </td><td> </td><td> </td><td> </td><... | <table><tr><td></td><td>Continuous level (1/day)</td><td>p-value</td><td colspan="4">Level of soy consumptionb</td></tr><tr><td></td><td></td><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>Total soy</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td... | <table><tr><td></td><td>Continuous level (1/day)</td><td>p-value</td><td colspan="4">Level of soy consumptionb</td></tr><tr><td></td><td></td><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>Relative risk</td><td>0.99 (0.91, 1.07)</td><td>0.770</td><td>1.00 Ref</td><td>0... |
ddbc4173dbf82afe6b348421eda2016ff41b5d1efa680becf5d4b59689589936.png | simple | <table><tr><td></td><td>No PORT <i>N</i> (%)</td><td></td><td>PORT <i>N</i> (%)</td><td></td><td><i>P</i> value</td></tr><tr><td>Number of patients</td><td>3211</td><td></td><td>2093</td><td></td><td></td></tr><tr><td>Year of diagnosis, median (range)</td><td>2007 (1988–2012)</td><td></td><td>2006 (1988–201... | <table><tr><td></td><td>No PORT N (%)</td><td></td><td>PORT N (%)</td><td></td><td>P value</td></tr><tr><td>Number of patients</td><td>3211</td><td></td><td>2093</td><td></td><td></td></tr><tr><td>Year of diagnosis, median (range)</td><td>2007 (1988–2012)</td><td></td><td>2006 (1988–2012)</td><td></td><td></td></tr><tr... | <table><tr><td>LNR (mean ± SD)</td><td>0.18 ± 0.23</td><td></td><td>0.17 ± 0.22</td><td></td><td></td></tr><tr><td>Lymph node status</td><td></td><td></td><td></td><td></td><td>< 0.001</td></tr><tr><td>Not examined</td><td>231</td><td>(7.2)</td><td>74</td><td>(3.5)</td><td></td></tr><tr><td>pN0</td><td>1118</td><td>(34... |
bebcee0596d3e5f056979f1919c38d8f111f066e86189cfc793e8924434909ca.png | complex | <table><tr><td></td><td>Workpiece</td><td>Upper Punch</td><td>Die</td><td>Lower Punch</td></tr><tr><td>Properties</td><td>Elastic-plastic</td><td colspan="3">Rigid</td></tr><tr><td>Material</td><td>C1010</td><td>SKH55</td><td>WC</td><td>SKH9</td></tr><tr><td>Mesh number</td><td>35,000</td><td colspan="3">30,000</td></t... | <table><tr><td></td><td>Workpiece</td></tr><tr><td>Properties</td><td>Elastic-plastic</td></tr><tr><td>Material</td><td>C1010</td></tr><tr><td>Mesh number</td><td>35,000</td></tr><tr><td>Hardness</td><td>HRC38</td></tr></table> | <table><tr><td>Upper Punch</td><td>Die</td><td>Lower Punch</td></tr><tr><td colspan="3">Rigid</td></tr><tr><td>SKH55</td><td>WC</td><td>SKH9</td></tr><tr><td colspan="3">30,000</td></tr><tr><td>HRC66</td><td>HRC77</td><td>HRC61</td></tr></table> |
1dbd93b934da2eba36e984ffe821734c4433794fa22b04446a1a68f647cad0c0.png | simple | <table><tr><td>ID</td><td>No-Attr BE</td><td>Sex BE</td><td>Age BE</td><td>Ped BE</td><td>All-Attr BE</td><td>All-Attr BE+CE</td><td>SSABE</td><td>SSABEG</td></tr><tr><td>rs6442089</td><td>74</td><td>72</td><td>74</td><td>66</td><td>35</td><td>55</td><td>57</td><td>24</td></tr><tr><td>rs1060407</td><td>76</td><td>66</t... | <table><tr><td>ID</td><td>No-Attr BE</td><td>Sex BE</td><td>Age BE</td><td>Ped BE</td><td>All-Attr BE</td><td>All-Attr BE+CE</td><td>SSABE</td><td>SSABEG</td></tr></table> | <table><tr><td>rs6442089</td><td>74</td><td>72</td><td>74</td><td>66</td><td>35</td><td>55</td><td>57</td><td>24</td></tr><tr><td>rs1060407</td><td>76</td><td>66</td><td>58</td><td>50</td><td>18</td><td>41</td><td>46</td><td>13</td></tr><tr><td>13rs3772219</td><td>2</td><td>2</td><td>6</td><td>20</td><td>52</td><td>44<... |
5ffa163eafeda7639f9440f584928de6a99b22c98eb4966b34b09fd27d416b3f.png | simple | <table><tr><td>LogMAR BCVA</td><td>Phacotrab group</td><td>Phaco group</td><td><i>P</i> Value</td></tr><tr><td>Mean preoperative ± SD</td><td>1.21 ± 0.49</td><td>1.23 ± 0.43</td><td>0.93*</td></tr><tr><td>Mean postoperative ± SD (6 mos)</td><td>0.82 ± 0.44</td><td>0.80 ± 0.38</td><td>0.91*... | <table><tr><td>LogMAR BCVA</td><td>Phacotrab group</td><td>Phaco group</td><td>P Value</td></tr><tr><td>Mean preoperative ± SD</td><td>1.21 ± 0.49</td><td>1.23 ± 0.43</td><td>0.93*</td></tr><tr><td>Mean postoperative ± SD (6 mos)</td><td>0.82 ± 0.44</td><td>0.80 ± 0.38</td><td>0.91*</td></tr><tr><td>Mean postoperative ... | <table><tr><td>± SD (12 mos)</td><td></td><td>.80 ± 0.39</td><td>*</td></tr><tr><td>P Value</td><td>0.003*</td><td><0.001*</td><td></td></tr></table> |
6a3f9042a23dd48a469b1d53eeb85201e0763c12fa01f90a122ca66857c24dbb.png | complex | <table><tr><td>ROI</td><td>BMD ratios in the bisphosphonates group</td><td>BMD ratios in the control group</td><td>WMD</td><td colspan="2">[95 % CI]</td><td><i>P</i> of chi-square</td><td><i>I</i><sup>2</sup></td><td>Selected model</td><td><i>P</i> for overall effect</td></tr><tr><td>1</td><td>97.556</td><td>90.840</td... | <table><tr><td>ROI</td><td>BMD ratios in the bisphosphonates group</td><td>BMD ratios in the control group</td><td>WMD</td><td colspan="2">[95 % CI]</td></tr><tr><td>1</td><td>97.556</td><td>90.840</td><td>6.364</td><td>2.122</td><td>10.606</td></tr><tr><td>2</td><td>96.275</td><td>93.488</td><td>2.479</td><td>1.886</t... | <table><tr><td>P of chi-square</td><td>I2</td><td>Selected model</td><td>P for overall effect</td></tr><tr><td>0</td><td>92 %</td><td>Random-effect model</td><td>0.003</td></tr><tr><td>0.564</td><td>0 %</td><td>Fixed-effect model</td><td><0.001</td></tr><tr><td>0.673</td><td>0 %</td><td>Fixed-effect model</td><td><0.00... |
cccff30ca213a757efe11de814de8a1843123923d3372b7a66a8fcaa32e1861d.png | simple | <table><tr><td></td><td>Normal</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td>Motor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <i>Median nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DML (ms)</td><td>≤ ... | <table><tr><td></td><td>Normal</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td>Motor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Median nerve</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DML (ms)</td><td>≤ 3,9</td><td>2,... | <table><tr><td>Amplitude (mV)</td><td>≥ 7</td><td>13,4</td><td>11</td><td></td><td>n.d.</td><td>20</td><td></td></tr><tr><td>Sural nerve</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>NCV (m/s)</td><td>≥ 41</td><td>34</td><td>not recordable</td><td>30</td><td>56,5</td><td>32</td><td>not... |
9ca2d13fcef9ff4fe0175c44d3923d50e93c96444d9e82ce38a2b78fe6290479.png | simple | <table><tr><td></td><td>Males</td><td>P</td><td>Females</td><td>P</td></tr><tr><td></td><td>(n = 24)</td><td></td><td>(n = 20)</td><td></td></tr><tr><td>Model R</td><td>0.28</td><td>0.80</td><td>0.79</td><td>0.004</td></tr><tr><td>Standardised coefficients (Beta)</td><td></td><td></td><td></td><td></td></tr><tr><td>BMI... | <table><tr><td></td><td>Males</td><td>P</td><td>Females</td><td>P</td></tr><tr><td></td><td>(n = 24)</td><td></td><td>(n = 20)</td><td></td></tr><tr><td>Model R</td><td>0.28</td><td>0.80</td><td>0.79</td><td>0.004</td></tr><tr><td>Standardised coefficients (Beta)</td><td></td><td></td><td></td><td></td></tr><tr><td>BMI... | <table><tr><td></td><td>Males</td><td>P</td><td>Females</td><td>P</td></tr><tr><td></td><td>(n = 24)</td><td></td><td>(n = 20)</td><td></td></tr><tr><td>Diet (1.5 g/d ALA vs. 9.5 g/d ALA)</td><td>0.02</td><td>0.94</td><td>0.63</td><td>0.003</td></tr><tr><td>Age</td><td>−0.15</td><td>0.56</td><td>−0.47</td><td>0.029</td... |
3599d918e2c832664ed6fc680d6e1ae85228867646328ac69a6754cea4efda3b.png | simple | <table><tr><td>Variable</td><td>β</td><td>p</td><td>OR</td><td>95% CI</td></tr><tr><td>Marital status</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Single</td><td>0.859</td><td>0.031</td><td>2.36</td><td>1.081 – 5.150</td></tr><tr><td>All others</td><td> </td><td> </td><td>1</td><td> </td></tr><tr... | <table><tr><td>Variable</td><td>β</td><td>p</td><td>OR</td><td>95% CI</td></tr><tr><td>Marital status</td><td></td><td></td><td></td><td></td></tr><tr><td>Single</td><td>0.859</td><td>0.031</td><td>2.36</td><td>1.081 – 5.150</td></tr><tr><td>All others</td><td></td><td></td><td>1</td><td></td></tr><tr><td>Migrant</td><... | <table><tr><td>All others</td><td></td><td></td><td>1</td><td></td></tr><tr><td>Income (n° of minimal wages)</td><td>0.054</td><td>0.026</td><td>1.056</td><td>1.007 – 1.107</td></tr></table> |
7fd6c503bfa681cc30487e53a0c0096aeb6a0d2a6e8fa7bfde49bc887c1c838f.png | simple | <table><tr><td>Factor</td><td>OR (95% CI)<sup>b</sup></td><td><i>P </i>value<sup>c</sup></td></tr><tr><td>Ultrasound examination</td><td>53.7 (28.6 to 83.5)</td><td>< 0.001</td></tr><tr><td>NT-proBNP</td><td>14.3 (8.1 to 29.4)</td><td>< 0.001</td></tr><tr><td>Orthopnea</td><td>6.9 (1.9 to 18.39</td><td>< 0.001... | <table><tr><td>Factor</td><td>OR (95% CI)b</td><td>P valuec</td></tr><tr><td>Ultrasound examination</td><td>53.7 (28.6 to 83.5)</td><td>< 0.001</td></tr><tr><td>NT-proBNP</td><td>14.3 (8.1 to 29.4)</td><td>< 0.001</td></tr><tr><td>Orthopnea</td><td>6.9 (1.9 to 18.39</td><td>< 0.001</td></tr><tr><td>Rales</td><td>5.1 (1... | <table><tr><td>Factor</td><td>OR (95% CI)b</td><td>P valuec</td></tr><tr><td>Asthma/COPD medications</td><td>0.12 (0.03 to 0.42)</td><td>0.028</td></tr><tr><td>Previous HF</td><td>7.4 (2.3 to 20.4)</td><td>< 0.001</td></tr><tr><td>Fever</td><td>0.17 (0.06 to 0.49)</td><td>0.017</td></tr></table> |
1bc70f623053499b37e6af1f77df82e3a004c9e129dd80fca58de8297f167a3c.png | complex | <table><tr><td>Expression</td><td>Gene</td><td>Meningioma (%)</td><td>Schwannoma (%)</td></tr><tr><td rowspan="3">Downregulation</td><td><i>FOS</i></td><td>90</td><td>65</td></tr><tr><td><i>ICAM1</i></td><td>71</td><td>61</td></tr><tr><td><i>FLY1</i></td><td>78</td><td>48</td></tr><tr><td>Upregulation</td><td><i>ITCAV<... | <table><tr><td>Expression</td><td>Gene</td><td>Meningioma (%)</td><td>Schwannoma (%)</td></tr><tr><td rowspan="2">Downregulation</td><td>FOS</td><td>90</td><td>65</td></tr><tr><td>ICAM1</td><td>71</td><td>61</td></tr></table> | <table><tr><td>Downregulation</td><td>FLY1</td><td>78</td><td>48</td></tr><tr><td>Upregulation</td><td>ITCAV</td><td>66</td><td>61</td></tr></table> |
604affeaa20dd229d69c3c1c3066db6135f89d683ecbd6342602d1081ae7305d.png | complex | <table><tr><td>Cluster number</td><td><i>x, y, z</i>a</td><td>Peak intensity</td><td>Cluster sizeb</td><td>Regionc</td><td>Brodmann's area</td></tr><tr><td colspan="6">Taking the Declive as ROI</td></tr><tr><td>1</td><td>−30, 3, −18</td><td>3.649</td><td>142</td><td>L Superior Temporal Gyrus/Inferior Pariet... | <table><tr><td>Cluster number</td><td>x, y, za</td><td>Peak intensity</td><td>Cluster sizeb</td><td>Regionc</td><td>Brodmann's area</td></tr><tr><td colspan="6">Taking the Declive as ROI</td></tr><tr><td>1</td><td>−30, 3, −18</td><td>3.649</td><td>142</td><td>L Superior Temporal Gyrus/Inferior Parietal Lobe</td><td>41,... | <table><tr><td>2</td><td>3, 27, 39</td><td>4.077</td><td>497</td><td>Superior Frontal Gyrus/Medial Frontal Gyrus</td><td>4, 6, 8, 9</td></tr><tr><td colspan="6">Taking the Striatum as ROI</td></tr><tr><td>1</td><td>9, 0, 54</td><td>3.632</td><td>151</td><td>R Anterior Cingulate Cortex</td><td>6, 23, 24</td></tr><tr><td... |
ecf8c58995a39e208d4a6707191083e6523cd0f056d2c3cfdea5a721d45af4d1.png | simple | <table><tr><td>Time of assessment</td><td><i>n</i></td><td>Mean</td><td>Median</td><td>Minimum</td><td>Maximum</td><td>SD</td><td><i>P</i>-value*</td></tr><tr><td>Preoperative</td><td>30</td><td>4.1</td><td>4.0</td><td>2.0</td><td>8.3</td><td>1.4</td><td></td></tr><tr><td>3-5 days</td><td>30</td><td>3.3</td><td>3.1</td... | <table><tr><td>Time of assessment</td><td>n</td><td>Mean</td><td>Median</td><td>Minimum</td><td>Maximum</td><td>SD</td><td>P-value*</td></tr><tr><td>Preoperative</td><td>30</td><td>4.1</td><td>4.0</td><td>2.0</td><td>8.3</td><td>1.4</td><td></td></tr><tr><td>3-5 days</td><td>30</td><td>3.3</td><td>3.1</td><td>1.8</td><... | <table><tr><td>1 month</td><td>30</td><td>3.0</td><td>2.9</td><td>2.0</td><td>4.6</td><td>0.7</td><td>0.019</td></tr><tr><td>6 months</td><td>30</td><td>3.0</td><td>3.1</td><td>1.1</td><td>5.0</td><td>0.8</td><td></td></tr><tr><td>1 year</td><td>30</td><td>3.1</td><td>3.2</td><td>1.5</td><td>5.4</td><td>0.8</td><td></t... |
ec6a0fb110cfbef19502385aeab5acee22ddd2e1c437887d19820b081da1e6ac.png | complex | <table><tr><td>Time Light</td><td colspan="2">Morning</td><td colspan="2">Mid-day</td><td colspan="2">Evening</td><td colspan="2">Total</td></tr><tr><td></td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td></tr><tr><td>Baseline start</td><td>21.23 (6.08) 13</t... | <table><tr><td>Time Light</td><td colspan="2">Morning</td><td colspan="2">Mid-day</td><td colspan="2">Evening</td><td colspan="2">Total</td></tr><tr><td></td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td></tr><tr><td>Baseline start</td><td>21.23 (6.08) 13</t... | <table><tr><td>Time Light</td><td colspan="2">Morning</td><td colspan="2">Mid-day</td><td colspan="2">Evening</td><td colspan="2">Total</td></tr><tr><td></td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td></tr><tr><td>of baseline week</td><td>5.85) 13</td><td... |
f794d8db5dd08b08841bfe71dc9ce0262d7d83cfb4e9517a599d7f3057334248.png | simple | <table><tr><td>Typer</td><td>Overall</td><td>HLA-A</td><td>HLA-B</td><td>HLA-C</td></tr><tr><td>Optitype (4-digit)</td><td>0.09</td><td>0.08</td><td>0.08</td><td>0.11</td></tr><tr><td>Polysolver (8-digit)</td><td>0.08</td><td>0.08</td><td>0.02</td><td>0.14</td></tr><tr><td>Polysolver (4-digit)</td><td>0.12</td><td>0.12... | <table><tr><td>Typer</td><td>Overall</td><td>HLA-A</td><td>HLA-B</td><td>HLA-C</td></tr></table> | <table><tr><td>Optitype (4-digit)</td><td>0.09</td><td>0.08</td><td>0.08</td><td>0.11</td></tr><tr><td>Polysolver (8-digit)</td><td>0.08</td><td>0.08</td><td>0.02</td><td>0.14</td></tr><tr><td>Polysolver (4-digit)</td><td>0.12</td><td>0.12</td><td>0.09</td><td>0.15</td></tr></table> |
f23ef114ab13a3f943e239c711422674c854675cf7dd46e74375ffaa9f753d2c.png | simple | <table><tr><td>Characteristics</td><td>New-onset CAE (<i>n</i> = 35)</td><td>Control (<i>n</i> = 33)</td><td><i>P</i> value</td></tr><tr><td>Age (years), mean ± SD (range)</td><td>7.3 ± 1.3 (5–10)</td><td>6.8 ± 1.1 (5–9)</td><td>0.14</td></tr><tr><td>Gender (boys/girls)</td><td>14/21</td><td>... | <table><tr><td>Characteristics</td><td>New-onset CAE (n = 35)</td><td>Control (n = 33)</td><td>P value</td></tr></table> | <table><tr><td>Age (years), mean ± SD (range)</td><td>7.3 ± 1.3 (5–10)</td><td>6.8 ± 1.1 (5–9)</td><td>0.14</td></tr><tr><td>Gender (boys/girls)</td><td>14/21</td><td>18/15</td><td>0.23</td></tr><tr><td>Age at onset, years (SD)</td><td>6.7 (1.3)</td><td>N/A</td><td>N/A</td></tr><tr><td>Duration of epilepsy (time to dia... |
692dbe42043b20ec2a9d3909bc522b96fd6b9774da8a25c8616b7439f1a62cdc.png | simple | <table><tr><td></td><td>2007</td><td>2008</td><td>2009</td><td>2010</td></tr><tr><td>Total number of insured persons</td><td>4 048 709</td><td>3 931 988</td><td>3 906 411</td><td>3 954 172</td></tr><tr><td>Age in years (mean)</td><td>43.0</td><td>43.5</td><td>43.7</td><td>43.7</td></tr><tr><td>Sex (men & women)</td... | <table><tr><td></td><td></td><td></td><td></td><td>2010</td></tr></table> | <table><tr><td></td><td>2007</td><td>2008</td><td>2009</td><td></td></tr><tr><td>Total number of insured persons</td><td>4 048 709</td><td>3 931 988</td><td>3 906 411</td><td>3 954 172</td></tr><tr><td>Age in years (mean)</td><td>43.0</td><td>43.5</td><td>43.7</td><td>43.7</td></tr><tr><td>Sex (men & women)</td><td>47.... |
ca44d3ff0e5523624c2690d04f0f8353876f507167e77c55eaf8c6726c3a24b2.png | complex | <table><tr><td>Age group (years)</td><td colspan="2"><i>Haemophilus influenzae</i> type b (invasive)</td><td colspan="2">Measles</td><td colspan="2">Meningococcal disease(invasive)</td><td colspan="2">Mumps</td><td colspan="2">Pertussis</td><td colspan="2">Pneumococcal disease(invasive)</td><td colspan="2">Rubella</td>... | <table><tr><td>Age group (years)</td><td colspan="2">Haemophilus influenzae type b (invasive)</td><td colspan="2">Measles</td><td colspan="2">Meningococcal disease(invasive)</td><td colspan="2">Mumps</td><td colspan="2">Pertussis</td><td colspan="2">Pneumococcal disease(invasive)</td><td colspan="2">Rubella</td><td col... | <table><tr><td>Age group (years)</td><td colspan="2">Haemophilus influenzae type b (invasive)</td><td colspan="2">Measles</td><td colspan="2">Meningococcal disease(invasive)</td><td colspan="2">Mumps</td><td colspan="2">Pertussis</td><td colspan="2">Pneumococcal disease(invasive)</td><td colspan="2">Rubella</td><td col... |
100859bd75ea00d882b8083884a1e07c4bd55c1cb1b9643f988e994b34696dc7.png | complex | <table><tr><td>Outcome</td><td><i>ID</i></td><td><i>GH</i></td><td><i>PE</i></td><td><i>HEELP</i></td><td><i>FGR</i></td><td><i>PL</i></td><td><i>Abruptio</i></td><td><i>Previa</i></td><td><i>DIC</i></td></tr><tr><td></td><td colspan="9">Cases with single mutation Pearson correlation 2-tailed significance</td></tr><tr>... | <table><tr><td>Outcome</td><td>ID</td></tr><tr><td></td><td>Cases with single mutation Pearson correlation 2-tailed significance</td></tr><tr><td rowspan="3">AT III deficiency</td><td>0</td></tr><tr><td>-0.035</td></tr><tr><td>0.541</td></tr><tr><td rowspan="3">Protein S deficiency</td><td>0</td></tr><tr><td>-0.024</td... | <table><tr><td>GH</td><td>PE</td><td>HEELP</td><td>FGR</td><td>PL</td><td>Abruptio</td><td>Previa</td><td>DIC</td></tr><tr><td colspan="8">Cases with single mutation Pearson correlation 2-tailed significance</td></tr><tr><td>2</td><td>6</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td><td>2</td></tr><tr><td>-0.034... |
cb05b29acc232d814175512e3bff78de24544b2ffb0226d8f252d30c697df300.png | simple | <table><tr><td>BehaviouralCorrelate</td><td>Brain region</td><td>Cerebral hemisphere</td><td>Cluster size (voxels)</td><td>p value</td></tr><tr><td>Combined groups</td><td>Anterior TL, OFC</td><td>R</td><td>107,453</td><td>0.02</td></tr><tr><td>bvFTD only</td><td>Anterior TL, OFC</td><td>Bilateral</td><td>318,805</td><... | <table><tr><td>BehaviouralCorrelate</td><td>Brain region</td><td>Cerebral hemisphere</td><td>Cluster size (voxels)</td><td>p value</td></tr><tr><td>Combined groups</td><td>Anterior TL, OFC</td><td>R</td><td>107,453</td><td>0.02</td></tr><tr><td>bvFTD only</td><td>Anterior TL, OFC</td><td>Bilateral</td><td>318,805</td><... | <table><tr><td>svPPA</td><td>Parahippocampal, fusiform gyri</td><td>2</td></tr></table> |
58da377859bba45d004d89b5cc5e08d3fd6557d0b2505e77e6a7d9b3fa838d28.png | complex | <table><tr><td></td><td colspan="2">Baseline</td><td colspan="2">Day 1</td><td colspan="2">Day 3</td><td colspan="2">Day 7</td></tr><tr><td></td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td></tr><tr><td>V<sub>T</sub>, mls</td><td>519 ... | <table><tr><td></td><td colspan="2">Baseline</td><td colspan="2">Day 1</td><td colspan="2">Day 3</td><td colspan="2">Day 7</td></tr><tr><td></td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td></tr><tr><td>VT, mls</td><td>519 ± 56</td><td>5... | <table><tr><td>PEEP,cm H2O</td><td>11.8 ± 0.7</td><td>14.2 ± 1.2</td><td>15 ± 1*</td><td>10 ± 0.5</td><td>12.1 ± 1.5</td><td>9.3 ± 1.4</td><td>8.5 ± 1.8</td><td>7.8 ± 2.0</td></tr><tr><td>Pplateau, cmH2O</td><td>28.4 ± 1.5</td><td>29 ± 1.5</td><td>27.6 ± 1.5</td><td>26.9 ± 1.4</td><td>24.2 ± 2.4</td><td>24 ± 2.1</td><t... |
d696a03d712cc441f2cec2f9eaac9df0b2cef8a1ae21c308aa48e93d6d290114.png | simple | <table><tr><td>Variable</td><td>C</td><td>F</td></tr><tr><td>Glucose (mg/dl)</td><td>83.6 ± 4.5</td><td>98.5 ± 10.5*</td></tr><tr><td>Triglycerides (mg/dl)</td><td>123.4 ± 49.0</td><td>268.3 ± 35.1*</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>91.7 ± 9.6</td><td>96.3 ± 15.5</td></tr>... | <table><tr><td>Variable</td><td>C</td><td>F</td></tr><tr><td>Glucose (mg/dl)</td><td>83.6 ± 4.5</td><td>98.5 ± 10.5*</td></tr><tr><td>Triglycerides (mg/dl)</td><td>123.4 ± 49.0</td><td>268.3 ± 35.1*</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>91.7 ± 9.6</td><td>96.3 ± 15.5</td></tr><tr><td>HDL cholesterol (mg/dl... | <table><tr><td>Catalase (U/ml)</td><td>42.2 ± 10.4</td><td>68.4 ± 6.8*</td></tr><tr><td>TBARS (μM)</td><td>16.5 ± 2.0</td><td>22.2 ± 4.4*</td></tr></table> |
33e02c7b3edb89dbba51c754138d1be212423f90d99d82be3508dadc28852ba1.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Normal versus normal-tension glaucoma</td></tr><tr><td>AUROC (SE)</td><td>Sn/Sp (Sp > 90%)</td></tr><tr><td>OCT-A whole image vessel density</td><td>0.950 (0.027)</td><td>82.14/92.00</td></tr><tr><td>OCT-A inside disc vessel density</td><td>0.931 (0.034)</td><td>78.57/... | <table><tr><td rowspan="2"></td><td>Normal versus normal-tension glaucoma</td></tr><tr><td>AUROC (SE)</td></tr><tr><td>OCT-A whole image vessel density</td><td>0.950 (0.027)</td></tr><tr><td>OCT-A inside disc vessel density</td><td>0.931 (0.034)</td></tr><tr><td>OCT-A peripapillary vessel density</td><td>0.830 (0.056)∗... | <table><tr><td>Normal versus normal-tension glaucoma</td></tr><tr><td>Sn/Sp (Sp > 90%)</td></tr><tr><td>82.14/92.00</td></tr><tr><td>78.57/92.00</td></tr><tr><td>60.71/92.00</td></tr><tr><td>60.71/92.00</td></tr><tr><td>21.43/92.00</td></tr><tr><td>28.57/92.00</td></tr><tr><td>92.86/92.00</td></tr><tr><td>75.00/96.00</... |
1e18001564d3955d571d4c8d5551a29160a94560bc67feb87a90e84e998202d5.png | complex | <table><tr><td>Variables</td><td>Overall</td><td>Somalian</td><td>Ethiopian</td><td>Eritrean</td><td>Gambian</td><td><i>P</i>-value</td></tr><tr><td>N</td><td>36,366</td><td>24,253</td><td>5631</td><td>4483</td><td>1999</td><td></td></tr><tr><td colspan="7">Age distribution, %</td></tr><tr><td> 0–14</td><td>38.1<... | <table><tr><td>Variables</td><td>Overall</td><td>Somalian</td><td>Ethiopian</td><td>Eritrean</td><td>Gambian</td><td>P-value</td></tr><tr><td>N</td><td>36,366</td><td>24,253</td><td>5631</td><td>4483</td><td>1999</td><td></td></tr><tr><td colspan="7">Age distribution, %</td></tr><tr><td>0–14</td><td>38.1</td><td>41.2</... | <table><tr><td>Variables</td><td>Overall</td><td>Somalian</td><td>Ethiopian</td><td>Eritrean</td><td>Gambian</td><td>P-value</td></tr><tr><td>%</td><td>3.3</td><td>9</td><td>6.6</td><td></td><td></td><td></td></tr><tr><td colspan="7">Marital status, %:</td></tr><tr><td>Unmarried</td><td>64.4</td><td>65.0</td><td>63.1</... |
922c912575c93673611f05923569ccfee0e6f5964fd6454ba8078474db1f4a41.png | complex | <table><tr><td colspan="3">Private Hospital</td><td colspan="3">National Data</td></tr><tr><td>YEAR</td><td>No. of Malaria cases</td><td><i>Plasmodium falciparum</i></td><td>YEAR</td><td>No. of Malaria Cases</td><td><i>Plasmodium falciparum</i></td></tr><tr><td>2006July -December</td><td>60</td><td>31</td><td>2006</td>... | <table><tr><td colspan="3">Private Hospital</td><td colspan="3">National Data</td></tr><tr><td>YEAR</td><td>No. of Malaria cases</td><td>Plasmodium falciparum</td><td>YEAR</td><td>No. of Malaria Cases</td><td>Plasmodium falciparum</td></tr><tr><td>2006July -December</td><td>60</td><td>31</td><td>2006</td><td>928</td><t... | <table><tr><td colspan="3">Private Hospital</td><td colspan="3">National Data</td></tr><tr><td>YEAR</td><td>No. of Malaria cases</td><td>Plasmodium falciparum</td><td>YEAR</td><td>No. of Malaria Cases</td><td>Plasmodium falciparum</td></tr><tr><td>2008Jan - July</td><td>18</td><td>10</td><td>2008</td><td>248</td><td>0<... |
d9f171a2b38ec65077f359c951decc08350027207c3bdf695925503577bbd30c.png | simple | <table><tr><td></td><td>Group I (Harvesting)</td><td>Group II (Preserving)</td><td><i>p</i> value*</td></tr><tr><td>Patients</td><td>61 (10 M & 51 F)</td><td>43 (1 M & 42 F)</td><td></td></tr><tr><td>Age (years)</td><td>14.0 (11 ~ 19)</td><td>13.8 (10 ~ 18)</td><td>0.71</td></tr><tr><td>Median f/u length (month... | <table><tr><td></td><td>Group I (Harvesting)</td><td>Group II (Preserving)</td><td>p value*</td></tr><tr><td>Patients</td><td>61 (10 M & 51 F)</td><td>43 (1 M & 42 F)</td><td></td></tr><tr><td>Age (ye</td><td></td><td>13.8 (10 ~</td><td>0</td></tr></table> | <table><tr><td>ars)</td><td>14.0 (11 ~ 19)</td><td> 18)</td><td>.71</td></tr><tr><td>Median f/u length (months)</td><td>60 (24 ~ 128)</td><td>73 (24 ~ 107)</td><td></td></tr><tr><td>Level fused</td><td>10.6 ± 1.7</td><td>10.0 ± 1.9</td><td>0.06</td></tr><tr><td>Duration of surgery (minutes)</td><td>216 ± 47</td><td>224... |
66bc6fc6054cd40c1964590de4f98f9a2833f2c7662d668a037d1d90c02c0931.png | simple | <table><tr><td>Station</td><td>Sampling date</td><td>Water depth (m)</td><td>Water temperature (°C)</td><td>Salinity (psu)</td><td>Flow velocity (mm s<sup>-1</sup>)</td></tr><tr><td>H1</td><td>Oct 25, 2012</td><td>3.8</td><td>16.0</td><td>25.0</td><td>129 ± 70</td></tr><tr><td>A3</td><td>Apr 3, 2013</td><td>3... | <table><tr><td>Station</td><td>Sampling date</td><td>Water depth (m)</td><td>Water temperature (°C)</td><td>Salinity (psu)</td><td>Flow velocity (mm s-1)</td></tr><tr><td>H1</td><td>Oct 25, 2012</td><td>3.8</td><td>16.0</td><td>25.0</td><td>129 ± 70</td></tr><tr><td>A3</td><td>Apr 3, 2013</td><td>3.4</td><td>19.1</td><... | <table><tr><td>Station</td><td>Sampling date</td><td>Water depth (m)</td><td>Water temperature (°C)</td><td>Salinity (psu)</td><td>Flow velocity (mm s-1)</td></tr><tr><td>A5</td><td>Apr 4, 2013</td><td>7.3</td><td>19.2</td><td>30.1</td><td>713 ± 498</td></tr></table> |
6b8920a09668a0bd57571665db872c5e27e9edc5ea9e2a79a94f52799984c58b.png | simple | <table><tr><td>Health education mode</td><td>Medical and health information from friends’ moments, group chats, public account sharing (open to all)</td><td>Normal health education information from the doctor in charge of you</td><td>Personalized health education information from the doctor in charge of you</td><... | <table><tr><td>Health education mode</td><td>Medical and health information from friends’ moments, group chats, public account sharing (open to all)</td><td>Normal health education information from the doctor in charge of you</td><td>Personalized health education information from the doctor in charge of you</td><td>Per... | <table><tr><td>Score</td><td>61.40</td><td>70.15</td><td>74.15</td><td>76.42</td></tr></table> |
21ab1152b997a5b6d34a538497fd19652a1095920065ab7652e0fd206ce77634.png | complex | <table><tr><td rowspan="2">CMs modalities</td><td colspan="5">Level of need</td></tr><tr><td>No %</td><td>Low %</td><td>Moderate %</td><td>High %</td><td>Some %</td></tr><tr><td>Herbal medicines</td><td>10</td><td>31</td><td>47</td><td>13</td><td>90 </td></tr><tr><td>Vitamins, minerals, trace elements</td><td>7</td><td... | <table><tr><td rowspan="2">CMs modalities</td><td colspan="5">Level of need</td></tr><tr><td>No %</td><td>Low %</td><td>Moderate %</td><td>High %</td><td>Some %</td></tr><tr><td>Herbal medicines</td><td>10</td><td>31</td><td>47</td><td>13</td><td>90</td></tr><tr><td>Vitamins, minerals, trace elements</td><td>7</td><td>... | <table><tr><td>Nutritional supplements</td><td>10</td><td>34</td><td>46</td><td>11</td><td>90</td></tr><tr><td>Homeopathic preparations</td><td>45</td><td>36</td><td>15</td><td>4</td><td>55</td></tr><tr><td>Aromatherapy products</td><td>50</td><td>37</td><td>10</td><td>4</td><td>50</td></tr><tr><td>Dietary intervention... |
0dee07e353c264e4652c02cf14e32339e601cfd5293b39932a565dfa1be16c0c.png | simple | <table><tr><td>Factor</td><td>mean± SD</td><td>Min</td><td>Max</td></tr><tr><td>Age (years)</td><td>53.04±4.53</td><td>42</td><td>60</td></tr><tr><td>Axial length (mm)</td><td>24.60±0.68</td><td>23.2</td><td>26.1</td></tr><tr><td>Operation time (min)</td><td>6.35±0.86</td><td>5</td><td>9</td></tr><t... | <table><tr><td>Factor</td><td>mean± SD</td><td>Min</td><td>Max</td></tr><tr><td>Age (years)</td><td>53.04±4.53</td><td>42</td><td>60</td></tr><tr><td>Axial length (mm)</td><td>24.60±0.68</td><td>23.2</td><td>26.1</td></tr><tr><td>Operation time (min)</td><td>6.35±0.86</td><td>5</td><td>9</td></tr><tr><td>EFT (sec)</td>... | <table><tr><td>Factor</td><td>mean± SD</td><td>Min</td><td>Max</td></tr><tr><td>ECD (superior)</td><td>2748.9±206.9</td><td>2245</td><td>3254</td></tr><tr><td>ECD (superotemporal)</td><td>2751.3±231.01</td><td>2321</td><td>3345</td></tr></table> |
c9834475112f983bde71c9067a274c8366f7ab769bbe61f35a71a59cfd7b06b6.png | complex | <table><tr><td></td><td colspan="2">1st Line</td><td colspan="2">Maintenance</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Mean</td><td>95% CI</td><td>Mean</td><td>95% CI</td><td>Diff.</td><td>95% CI</td><td><i>F</i>-value</td><td><i>p</i>-value</td></tr><tr><td>Dyspnoea</td><td>23.0</td><td>19.9-26.0</... | <table><tr><td></td><td colspan="2">1st Line</td><td colspan="2">Maintenance</td><td></td><td></td></tr><tr><td></td><td>Mean</td><td>95% CI</td><td>Mean</td><td>95% CI</td><td>Diff.</td><td>95% CI</td></tr><tr><td>Dyspnoea</td><td>23.0</td><td>19.9-26.0</td><td>21.2</td><td>0.0-45.4</td><td>1.73</td><td>−22.6-26.1</td... | <table><tr><td></td><td></td></tr><tr><td>F-value</td><td>p-value</td></tr><tr><td>0.230</td><td>0.632</td></tr><tr><td>1.943</td><td>0.165</td></tr><tr><td>0.273</td><td>0.603</td></tr><tr><td>0.183</td><td>0.670</td></tr><tr><td>1.408</td><td>0.237</td></tr><tr><td>1.711</td><td>0.192</td></tr><tr><td>15.116</td><td>... |
c690f669e4929b22c6404ec6ff0c8274c4e53cb80e25268191157847c2f91bce.png | complex | <table><tr><td rowspan="2"> </td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td rowspan="2">P<sup>*</sup></td></tr><tr><td>Healthy children</td><td>Ambulant sick children</td><td>Non ambulant sick children</td></tr><tr><td> </td><td><i>n = 126</i></td><td><i>n = 99</i></td><td><i>n = 36</i></td><td> </td></tr><tr>... | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td rowspan="2">P*</td></tr><tr><td>Healthy children</td><td>Ambulant sick children</td><td>Non ambulant sick children</td></tr><tr><td></td><td>n = 126</td><td>n = 99</td><td>n = 36</td><td></td></tr></table> | <table><tr><td></td><td>(%1)</td><td>(%1)</td><td>(%1)</td><td></td></tr><tr><td>Direct benefits to the parent’s own child of participating in the study</td><td>85.7</td><td>100.0</td><td>100.0</td><td>0.88</td></tr><tr><td>Benefits to the general population</td><td>93.6</td><td>87.2</td><td>27.6</td><td>0.001</td></tr... |
2a900027960ce72ce20a1b0109c95ebc2e3325e84f14adb2b9a2f7969c16f6eb.png | simple | <table><tr><td>Type of histopathology</td><td><i>n</i> (%)</td></tr><tr><td>Metaplastic carcinoma, spindle cells component</td><td>10 (25.0)</td></tr><tr><td>Metaplastic carcinoma, producing mucin</td><td>3 (7.5)</td></tr><tr><td>Metaplastic carcinoma, liposarcoma component</td><td>2 (5.0)</td></tr><tr><td>Metaplastic ... | <table><tr><td>Type of histopathology</td><td>n (%)</td></tr><tr><td>Metaplastic carcinoma, spind</td><td>10 (25.</td></tr></table> | <table><tr><td>Type of histopathology</td><td>n (%)</td></tr><tr><td>le cells component</td><td>0)</td></tr><tr><td>Metaplastic carcinoma, producing mucin</td><td>3 (7.5)</td></tr><tr><td>Metaplastic carcinoma, liposarcoma component</td><td>2 (5.0)</td></tr><tr><td>Metaplastic carcinoma, squamous cell</td><td>1 (2.5)</... |
0b61b80b9a77e9ce0bf65890698828250869eab351e582176a28a23573d2aa1d.png | simple | <table><tr><td>Nucleotide no.</td><td>Exon</td><td>Original*</td><td>Mutant</td><td>Amino acid change</td><td>Frequency in Japanese</td></tr><tr><td>590</td><td>IV</td><td>A</td><td>C</td><td>Asn to Thr</td><td>15%</td></tr><tr><td>800</td><td>V</td><td>T</td><td>C</td><td>Leu to Pro</td><td>40%</td></tr></table> | <table><tr><td>Nucleotide no.</td><td>Exon</td><td>Original*</td><td>Mutant</td><td>Amino acid change</td><td>Frequency in Japanese</td></tr></table> | <table><tr><td>590</td><td>IV</td><td>A</td><td>C</td><td>Asn to Thr</td><td>15%</td></tr><tr><td>800</td><td>V</td><td>T</td><td>C</td><td>Leu to Pro</td><td>40%</td></tr></table> |
3122a15d01ea5a67484635b27d91652be714f1464e5a6e0a656dff531d394e58.png | simple | <table><tr><td>Head resection volume groups*</td><td>Number of head resections performed</td><td>Non-head resection volume groups</td><td>Number of non-head resections performed</td></tr><tr><td>High volume years</td><td></td><td>High volume years</td><td></td></tr><tr><td>2002</td><td>42</td><td>2000</td><td>28</td></... | <table><tr><td>Head resection volume groups*</td></tr><tr><td>High volume years</td></tr><tr><td>2002</td></tr><tr><td>2000</td></tr><tr><td>1998</td></tr><tr><td>2001</td></tr><tr><td>1999</td></tr><tr><td>Medium volume years</td></tr><tr><td>1997</td></tr><tr><td>1995</td></tr><tr><td>2003</td></tr><tr><td>1993</td><... | <table><tr><td>Number of head resections performed</td><td>Non-head resection volume groups</td><td>Number of non-head resections performed</td></tr><tr><td></td><td>High volume years</td><td></td></tr><tr><td>42</td><td>2000</td><td>28</td></tr><tr><td>38</td><td>2002</td><td>22</td></tr><tr><td>33</td><td>1999</td><t... |
bda65605da1e46eb2ceb01469655f705d293ffbdb10b4ed16bfeb336f5fd78c9.png | simple | <table><tr><td>PlasmoDB ID</td><td>PlasmoDB annotation</td><td>Motifs</td><td>Key</td><td>Refs</td></tr><tr><td>PPP group</td><td></td><td></td><td></td><td></td></tr><tr><td>PF14_0630</td><td>protein serine/threonine phosphatase</td><td></td><td>A</td><td>42</td></tr><tr><td>PF14_0142</td><td>serine/threonine protein ... | <table><tr><td>PlasmoDB ID</td><td>PlasmoDB annotation</td><td>Motifs</td><td>Key</td><td>Refs</td></tr><tr><td>PPP group</td><td></td><td></td><td></td><td></td></tr><tr><td>PF14_0630</td><td>protein serine/threonine phosphatase</td><td></td><td>A</td><td>42</td></tr><tr><td>PF14_0142</td><td>serine/threonine protein ... | <table><tr><td>L13P1.274</td><td>n phosphatase pfPp5</td><td></td><td></td><td></td></tr><tr><td>PF13_0222</td><td>RNA lariat debranching enzyme, putative</td><td></td><td>K</td><td></td></tr><tr><td>PFA0390w</td><td>DNA repair exonuclease, putative</td><td></td><td>L</td><td></td></tr><tr><td>PF14_0064</td><td>vacuola... |
e34824c23c32e791b71723c285fe6fdec920f18cbde76bb598015fe8a91ac443.png | simple | <table><tr><td>Sample</td><td>Thickness, mm</td><td>Fiber Weight Fraction, %</td><td>Fiber Volume Fraction, %</td></tr><tr><td>PLA</td><td>0.740 ± 0.020</td><td>-</td><td>-</td></tr><tr><td>PLA-Flax</td><td>0.698 ± 0.016</td><td>38.2 ± 1.6</td><td>30.6 ± 0.4</td></tr><tr><td>PLA-Jute</td><td>0.750 &... | <table><tr><td>Sample</td><td>Thickness, mm</td><td>Fiber Weight Fraction, %</td><td>Fiber Volume Fraction, %</td></tr><tr><td>PLA</td><td>0.740 ± 0.020</td><td>-</td><td>-</td></tr><tr><td>PLA</td><td>0.</td><td></td><td>30</td></tr></table> | <table><tr><td>-Flax</td><td>698 ± 0.016</td><td>38.2 ± 1.6</td><td>.6 ± 0.4</td></tr><tr><td>PLA-Jute</td><td>0.750 ± 0.021</td><td>44.4 ± 0.9</td><td>41.1 ± 1.2</td></tr></table> |
efdf6c160813738a40b6acd6d396cd02ecdcc06b4c214b6759fa81e74ff9e94c.png | simple | <table><tr><td>Preoperative signs</td><td>Frequency</td></tr><tr><td><i>Reflexes</i></td><td> </td></tr><tr><td>Normal upper extremity reflex</td><td>30, 44.1</td></tr><tr><td>Hyperreflexia of upper extremity</td><td>25, 36.8</td></tr><tr><td>Hyporeflexia of upper extremity</td><td>13, 19.1</td></tr><tr><td>Normal lowe... | <table><tr><td>Preoperative signs</td></tr><tr><td>Reflexes</td></tr><tr><td>Normal upper extremity reflex</td></tr><tr><td>Hyperreflexia of upper extremity</td></tr><tr><td>Hyporeflexia of upper extremity</td></tr><tr><td>Normal lower extremity reflex</td></tr><tr><td>Hyperreflexia in lower extremity</td></tr><tr><td>... | <table><tr><td>Frequency</td></tr><tr><td></td></tr><tr><td>30, 44.1</td></tr><tr><td>25, 36.8</td></tr><tr><td>13, 19.1</td></tr><tr><td>43, 63.2</td></tr><tr><td>22, 32.4</td></tr><tr><td>3, 4.4</td></tr><tr><td></td></tr><tr><td>2, 2.9</td></tr><tr><td>48, 70.6</td></tr><tr><td>18, 26.5</td></tr><tr><td></td></tr><t... |
26ed47ea7353fe8e53ee376aeed2515473f7ff57f57862bfef5693e5c7c3d683.png | complex | <table><tr><td rowspan="2">Gender</td><td rowspan="2">Expert diagnosis</td><td colspan="4">SCAT-B diagnosis (<i>N</i>, %)</td><td>Predictability (%)</td><td>Kappa</td></tr><tr><td>TE</td><td>SE</td><td>SY</td><td>Total</td></tr><tr><td rowspan="3">Males</td><td>TE</td><td>287 (80.2)</td><td>18 (5)</td><td>53 (14.8)</td... | <table><tr><td rowspan="2">Gender</td><td rowspan="2">Expert diagnosis</td><td colspan="4">SCAT-B diagnosis (N, %)</td><td>Predictability (%)</td><td>Kappa</td></tr><tr><td>TE</td><td>SE</td><td>SY</td><td>Total</td><td colspan="2"></td></tr><tr><td rowspan="3">Males</td><td>TE</td><td>287 (80.2)</td><td>18 (5)</td><td... | <table><tr><td>Females</td><td>SY</td><td>149 (28.7)</td><td>111 (21.3)</td><td>260 (50)</td><td>520 (100)</td><td>767 (54.2)</td><td>.298</td></tr></table> |
3c0b483afe0e8ec51fcb1c9291088ed1bd1d89659478527b3a2cd2cbb6df5d56.png | complex | <table><tr><td rowspan="2">Characteristic</td><td>Placebo</td><td>Desvenlafaxine</td><td>Desvenlafaxine</td></tr><tr><td>(n = 223)</td><td>10 mg/d (n = 226)</td><td>50 mg/d (n = 224)</td></tr><tr><td>Age, y</td><td>42 ± 13</td><td>41 ± 14</td><td>43 ± 14</td></tr><tr><td>Age group, n (%)</td><td> </td><t... | <table><tr><td>Characteristic</td><td>Placebo</td><td>Desvenlafaxine</td><td>Desvenlafaxine</td></tr></table> | <table><tr><td>Characteristic</td><td>(n = 223)</td><td>10 mg/d (n = 226)</td><td>50 mg/d (n = 224)</td></tr><tr><td>Age, y</td><td>42 ± 13</td><td>41 ± 14</td><td>43 ± 14</td></tr><tr><td>Age group, n (%)</td><td></td><td></td><td></td></tr><tr><td>18-64 y</td><td>215 (96)</td><td>212 (94)</td><td>213 (95)</td></tr><t... |
e51cc548cc41a8f0af820f54bfc27eb8b4d232d45b2c7c4cb60c34947f2719d9.png | complex | <table><tr><td colspan="7">Age <65 years (n = 1052)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td>0</td><td>12/137</td><td>1</td><td> </td><td> </td><td>91.5%</td><td>84.7-95.4%</td></tr><tr><td>1</td><td>47/450</td><td>... | <table><tr><td colspan="7">Age <65 years (n = 1052)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td>0</td><td>12/137</td><td>1</td><td></td><td></td><td>91.5%</td><td>84.7-95.4%</td></tr><tr><td>1</td><td>47/450</td><td>1.44<... | <table><tr><td colspan="7">Age <65 years (n = 1052)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td colspan="7">5+ years (n = 1079)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td... |
710af7c71595f11c985b8d85e58578932080a71de3f6fddcbe8bd661ded190f2.png | simple | <table><tr><td></td><td>Onset < 20 y.o.</td><td>Onset >40 y.o.</td><td>Abdominal </td><td>C1q < 50%</td></tr><tr><td></td><td>% pts.</td><td>% pts.</td><td>% pts.</td><td>%pts</td></tr><tr><td>Acquired angioedema</td><td>0</td><td>94</td><td>48</td><td>70</td></tr><tr><td>Hereditary angioedema</td><td>12</td><... | <table><tr><td></td><td>Onset < 20 y.o.</td><td>Onset >40 y.o.</td><td>Abdominal</td><td>C1q < 50%</td></tr><tr><td></td><td>% pts.</td><td>% pts.</td><td>% pts.</td><td>%pts</td></tr></table> | <table><tr><td>Acquired angioedema</td><td>0</td><td>94</td><td>48</td><td>70</td></tr><tr><td>Hereditary angioedema</td><td>12</td><td>3</td><td>87</td><td>< 5</td></tr></table> |
90b1091e018aa45a0635987add68c5e344d5acf29d963bee6674cd9ffa2b8a34.png | complex | <table><tr><td></td><td>BudesonideNanodispersion </td><td colspan="2">BudesonideMicrosuspension </td></tr><tr><td>Inhalation Filter (percent of the nominal dose)</td><td colspan="2">14.24 (2.51)</td><td>14.97 (4.3)</td></tr><tr><td>Exhalation Filter (percent of the nominal dose)</td><td colspan="2">14.92 (3.21)</td><td... | <table><tr><td></td><td>Budes</td><td colspan="2">BudesonideMicros</td></tr></table> | <table><tr><td></td><td>onideNanodispersion</td><td colspan="2">uspension</td></tr><tr><td>Inhalation Filter (percent of the nominal dose)</td><td colspan="2">14.24 (2.51)</td><td>14.97 (4.3)</td></tr><tr><td>Exhalation Filter (percent of the nominal dose)</td><td colspan="2">14.92 (3.21)</td><td>15.27 (4.48)</td></tr>... |
58423c3e7c5925e67f1159f5e44f2ef4b498a09dd251cac1e8ce6e6472a3db43.png | complex | <table><tr><td>Factor</td><td><i>p</i> in univariate regression<sup>*</sup></td><td><i>p</i> in multivariate regression <sup>°</sup></td><td>Odds ratio in multivariate regression [95% CI]</td></tr><tr><td colspan="4">Predictive of complaint specificity</td></tr><tr><td> Age</td><td>0.171</td><td rowspan="2" colspa... | <table><tr><td>Factor</td><td>p in univariate regression*</td><td>p in multivariate regression °</td><td>Odds ratio in multivariate regression [95% CI]</td></tr><tr><td colspan="4">Predictive of complaint specificity</td></tr><tr><td>Age</td><td>0.171</td><td rowspan="2" colspan="2"></td></tr><tr><td>Gender</td><td>0.4... | <table><tr><td>Length of hospital stay</td><td>0.029</td><td>0.025</td><td>1.001 [1–1.002]</td></tr><tr><td>Vague diagnosis at ED discharge</td><td>0.923</td><td colspan="2"></td></tr><tr><td>Mortality</td><td>0.054</td><td>0.087</td><td>1.922 [0.909–4.065]</td></tr></table> |
7e7a8f96a42ccc8ba39d52078ef6734fe3a5a84af5b008508102e3fc0dd03b85.png | complex | <table><tr><td colspan="3">MEN</td><td colspan="3">WOMEN</td></tr><tr><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td></tr><tr><td><i>Influential for high SOC</i></td><td></td><td></td><td><i>Influential for high SOC</i></td><td></td><td></td></tr><tr><td> Bread</td><... | <table><tr><td colspan="3">MEN</td><td colspan="3">WOMEN</td></tr><tr><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td></tr><tr><td>Influential for high SOC</td><td></td><td></td><td>Influential for high SOC</td><td></td><td></td></tr><tr><td>Bread</td><td>+</td><td>2.... | <table><tr><td>Pasta</td><td>-</td><td>2.14</td><td>Potato salad</td><td>-</td><td>1.98</td></tr><tr><td>Candies</td><td>-</td><td>2.02</td><td>Soft drinks</td><td>-</td><td>1.94</td></tr><tr><td>Sausage as main course</td><td>-</td><td>1.97</td><td>French fries</td><td>-</td><td>1.89</td></tr><tr><td>Hamburgers</td><t... |
f62f1ef894b06aac69e04edfcb54bdbcb5fbe72dcf6d4b8a765469bf86452c7a.png | complex | <table><tr><td>Anthropometric</td><td><i>p</i></td><td>FFQ Intake</td><td><i>p</i></td><td>Model R-squared</td><td>FFQ—Plasma Correlation</td><td>Correlation 95% CI</td></tr><tr><td colspan="7">Plasma α-carotene</td></tr><tr><td></td><td></td><td>α-carotene</td><td><0.001</td><td>0.26</td><td>0.52</t... | <table><tr><td>Anthropometric</td><td>p</td><td>FFQ Intake</td></tr><tr><td colspan="3">Plasma α-carotene</td></tr><tr><td></td><td></td><td>α-carotene</td></tr><tr><td>BMI</td><td>0.004</td><td>α-carotene</td></tr><tr><td>BMI</td><td>0.001</td><td></td></tr><tr><td colspan="3">Plasma β-carotene</td></tr><tr><td></td><... | <table><tr><td>p</td><td>Model R-squared</td><td>FFQ—Plasma Correlation</td><td>Correlation 95% CI</td></tr><tr><td colspan="4">Plasma α-carotene</td></tr><tr><td><0.001</td><td>0.26</td><td>0.52</td><td>0.35, 0.69</td></tr><tr><td><0.001</td><td>0.34</td><td>0.49</td><td>0.33, 0.64</td></tr><tr><td></td><td>0.11</td><... |
f60defdc1e8d09ea57669fb9a1291ae1f4a238f6ed2c81500a53cf55be848cd0.png | simple | <table><tr><td>Marker name</td><td>Region</td><td>Chr</td><td>Position</td><td>SNP quality</td><td>Alleles (A/B)</td><td>EAF (B allele)</td><td>Effect size for B allele (95% CI)</td><td><i>P</i></td><td>Gene context</td></tr><tr><td>rs377070</td><td>4q27</td><td>4</td><td>123629002</td><td>0.99</td><td>C/G</td><td>0.38... | <table><tr><td>Marker name</td><td>Region</td><td>Chr</td><td>Position</td><td>SNP quality</td><td>Alleles (A/B)</td><td>EAF (B allele)</td><td>Effect size for B allele (95% CI)</td><td>P</td><td>Gene context</td></tr><tr><td>rs377070</td><td>4q27</td><td>4</td><td>123629002</td><td>0.99</td><td>C/G</td><td>0.388</td><... | <table><tr><td>rs78587638</td><td>2q14.2</td><td>2</td><td>119187509</td><td>0.98</td><td>A/G</td><td>0.842</td><td>−0.037 (−0.051, −0.023)</td><td>4.2 × 10−7</td><td>INSIG2---[]---EN1</td></tr><tr><td>rs12133641</td><td>1q21.3</td><td>1</td><td>154428283</td><td>>0.99</td><td>A/G</td><td>0.395</td><td>0.028 (0.017, 0.... |
bff23076e8335b4b7f39e449062bd2255dbcfde15b4c45c5916234aefcdbfd94.png | simple | <table><tr><td></td><td>Phase I - 2011 (<i>n</i> = 1054) %</td><td>Phase II - 2012 (<i>n</i> = 1105) %</td><td>Phase III - 2013 (<i>n</i> = 1854) %</td><td><i>P**</i></td></tr><tr><td>Location:</td><td></td><td></td><td></td><td><i>p</i> < 0.001</td></tr><tr><td>• Operating room</td><td>1.2</td><td>1.8</td><td... | <table><tr><td></td><td>Phase I - 2011 (n = 1054) %</td><td>Phase II - 2012 (n = 1105) %</td><td>Phase III - 2013 (n = 1854) %</td><td>P**</td></tr><tr><td>Location:</td><td></td><td></td><td></td><td>p < 0.001</td></tr><tr><td>• Operating room</td><td>1.2</td><td>1.8</td><td>1.5</td><td></td></tr><tr><td>• Medical sur... | <table><tr><td>• B</td><td>25.8</td><td>34.8</td><td>65.1</td><td></td></tr><tr><td>• C</td><td>35.7</td><td>35.2</td><td>27.5</td><td></td></tr><tr><td>• D</td><td>8.0</td><td>13.8</td><td>4.6</td><td></td></tr><tr><td>• E, F, H, G or I</td><td>1.3</td><td>2.1</td><td>0.5</td><td></td></tr><tr><td>Error accountability... |
b4d22e199d866e6baffd015a70fad986801e75455c3cdaa50570909526b3e7c6.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of cases.</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>HR ratio</td><td>95%CI</td><td>P-value</td><td>HR ratio</td><td>95%CI</td><td>P-value</td></tr><tr><td>Age(years)</td><td></td><td>1.009</td><td>0.991... | <table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of cases.</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>HR ratio</td><td>95%CI</td><td>P-value</td><td>HR ratio</td><td>95%CI</td><td>P-value</td></tr><tr><td>Age(years)</td><td></td><td>1.009</td><td>0.991... | <table><tr><td>rosa</td><td>66</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>To the surrounding tissue</td><td>31</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Histologic type</td><td></td><td>1.61</td><td>1.155-2.245</td><td>0.005**</td><td>1.615</td><td>1.138-2.293</t... |
3d97d5d57b9f6af7609ba4fc3cabca18552f5cb2439f2df3373e7efbebad134d.png | simple | <table><tr><td></td><td>MBA</td><td>LEBA</td></tr><tr><td>Deep squat</td><td>2.20 ± 0.79</td><td>2.50 ± 0.71</td></tr><tr><td>Hurdle step</td><td>1.80 ± 0.63</td><td>1.80 ± 0.79</td></tr><tr><td>Inline lunge</td><td>2.10 ± 0.74</td><td>2.70 ± 0.48 *</td></tr><tr><td>Shoulder mobility</td><... | <table><tr><td></td><td>MBA</td><td>LEBA</td></tr><tr><td>Deep squat</td><td>2.20 ± 0.79</td><td>2.50 ± 0.71</td></tr><tr><td>Hurdle step</td><td>1.80 ± 0.63</td><td>1.80 ± 0.79</td></tr><tr><td>Inline lunge</td><td>2.10 ± 0.74</td><td>2.70 ± 0.48 *</td></tr><tr><td>Shoulder mobility</td><td>1.40 ± 0.52</td><td>1.90 ± ... | <table><tr><td></td><td>MBA</td><td>LEBA</td></tr><tr><td>Total</td><td>13.40 ± 2.17</td><td>15.40 ± 1.90 *</td></tr></table> |
89b272e26e7f07c84ec5445239f9122cd6faa1f632c9fc0612fbef0658900214.png | simple | <table><tr><td>Survey/Questionnaire</td><td>Scheduled at</td><td>Contents</td><td>Conducted by *</td><td>Consent/Reconsent</td></tr><tr><td>Women's Enrollment Survey</td><td>Beginning of trial</td><td>Baseline census of all women of reproductive age, enrollment into surveillance</td><td>FD</td><td>Y</td></tr><tr><td>Ne... | <table><tr><td>Survey/Questionnaire</td><td>Scheduled at</td><td>Contents</td><td>Conducted by *</td></tr><tr><td>Women's Enrollment Survey</td><td>Beginning of trial</td><td>Baseline census of all women of reproductive age, enrollment into surveillance</td><td>FD</td></tr><tr><td>Newly Married Woman Survey</td><td>Ong... | <table><tr><td>Consent/Reconsent</td></tr><tr><td>Y</td></tr><tr><td>Y</td></tr><tr><td>Y, for urine test</td></tr><tr><td>Y</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>N</td></tr><tr><td>Y</td></tr><tr><td>Y</td></tr><tr><td>Y</td><... |
400e7849e6f7a74551c28474b110f7a1914941d09b51f5eadd3462869efc6a78.png | simple | <table><tr><td> </td><td>70 OR patients(<i>n</i>, %)</td><td>49 EVAR patients (<i>n</i>, %)</td><td><i>p</i></td></tr><tr><td>In-hospital</td><td> </td><td> </td><td> </td></tr><tr><td> Reintervention</td><td>1, 1.4</td><td>2, 4</td><td>0.36</td></tr><tr><td> Mortality</td><td>0, 0</td><td>0, 0</td><td>NA</td></tr><tr>... | <table><tr><td></td><td>70 OR patients(n, %)</td><td>49 EVAR patients (n, %)</td><td>p</td></tr><tr><td>In-hospital</td><td></td><td></td><td></td></tr><tr><td>Reintervention</td><td>1, 1.4</td><td>2, 4</td><td>0.36</td></tr><tr><td>Mortality</td><td>0, 0</td><td>0, 0</td><td>NA</td></tr><tr><td>30-day</td><td></td><td... | <table><tr><td>tality</td><td> 0</td><td>0, 0</td><td>NA</td></tr><tr><td>Long-term</td><td></td><td></td><td></td></tr><tr><td>Reintervention</td><td>8, 11.4</td><td>4, 8.1</td><td>0.39</td></tr><tr><td>Mortality</td><td>3, 4.2</td><td>4, 8.1</td><td>0.38</td></tr></table> |
8429ea52468625bcddee453360339adef31fe9ec37aab284a7b31896d1d3a3c2.png | simple | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Number of patients</td><td>112</td></tr><tr><td>Tissue samples analyzed</td><td>224</td></tr><tr><td>Sex</td><td></td></tr><tr><td> male</td><td>27</td></tr><tr><td> female</td><td>85</td></tr><tr><td>Age</td><td></td></tr><tr><td> < 45y</td><td>49</... | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Number of patients</td><td>112</td></tr><tr><td>Tissue samples analyzed</td><td>224</td></tr><tr><td>Sex</td><td></td></tr></table> | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>male</td><td>27</td></tr><tr><td>female</td><td>85</td></tr><tr><td>Age</td><td></td></tr><tr><td>< 45y</td><td>49</td></tr><tr><td>≥ 45y</td><td>63</td></tr><tr><td>Tumor size*</td><td></td></tr><tr><td>T1</td><td>63</td></tr><tr><td>T2</td><td>36</td>... |
56948a3b41e9a38c87352b9e3011a171bc9e9dcbb5a19bc70cdefc335cd3bcf7.png | complex | <table><tr><td>Outcome</td><td>Controls: no transfusion in ED group (<i>n</i> = 204)</td><td>Cases: transfusion group (<i>n</i> = 204)</td><td>Odds ratio or between-group difference (95% CI)</td><td><i>P</i> value*</td></tr><tr><td>Primary composite outcome, <i>n</i> (%)</td><td>26 (12.7)</td><td>28 (13.7)</td><td>0.91... | <table><tr><td>Outcome</td><td>Controls: no transfusion in ED group (n = 204)</td><td>Cases: transfusion group (n = 204)</td><td>Odds ratio or between-group difference (95% CI)</td><td>P value*</td></tr><tr><td>Primary composite outcome, n (%)</td><td>26 (12.7)</td><td>28 (13.7)</td><td>0.91 (0.48–1.72)</td><td>0.77</t... | <table><tr><td>ICU-free</td><td>24.7 (8.3)</td><td>23.7 (9.0)</td><td>0.9 (−0.8–2.6)</td><td>0.30</td></tr><tr><td>Hospital-free</td><td>20.0 (8.5)</td><td>18.6 (9.1)</td><td>1.4 (−0.3–3.1)</td><td>0.11</td></tr><tr><td>RRT, n (%)</td><td>18 (8.8)</td><td>7 (3.4)</td><td>0.37 (0.15–0.90)</td><td>0.02</td></tr><tr><td>M... |
f8954e158c7b0fba57a74fa675db3a203e0cbd63cf47769b47b4e902feea9756.png | complex | <table><tr><td></td><td colspan="2">Training</td><td colspan="2">Development</td><td colspan="2">Test</td></tr><tr><td>Year</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td></tr><tr><td>2009</td><td>800</td><td>0</td><td>150</td><td>0</td><td>260</td><td>0</td></tr><tr><t... | <table><tr><td></td><td colspan="2">Training</td><td colspan="2">Development</td><td colspan="2">Test</td></tr><tr><td>Year</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td></tr></table> | <table><tr><td>2009</td><td>800</td><td>0</td><td>150</td><td>0</td><td>260</td><td>0</td></tr><tr><td>2011</td><td>800</td><td>108</td><td>150</td><td>109</td><td>260</td><td>87</td></tr><tr><td>2013</td><td>0</td><td>222</td><td>0</td><td>249</td><td>0</td><td>305</td></tr></table> |
303085ec0b3aba5150058adba56440079272e41cef53ae1eb5be34cdd89347a8.png | simple | <table><tr><td> </td><td>All PCa</td><td>Sign PCa</td><td>Insig PCa</td></tr><tr><td>Sensitivity</td><td>96</td><td>98</td><td>91</td></tr><tr><td>Specificity</td><td>32</td><td>22</td><td>13</td></tr><tr><td>NPV</td><td>75</td><td>92</td><td>83</td></tr><tr><td>PPV</td><td>78</td><td>56</td><td>23</td></tr></table> | <table><tr><td></td><td>All PCa</td><td>Sign PCa</td><td>Insig PCa</td></tr><tr><td>Sensitivity</td><td>96</td><td>98</td><td>91</td></tr><tr><td>Specificity</td><td>32</td><td>22</td><td>13</td></tr><tr><td>NPV</td><td>75</td><td>92</td><td>83</td></tr></table> | <table><tr><td>PPV</td><td>78</td><td>56</td><td>23</td></tr></table> |
654ed62e6b7d73fd0bc18c62ad3c2f6e3cc67a07ebb8e6ac8a5d7e579b8a04c5.png | complex | <table><tr><td rowspan="2">Trait</td><td colspan="2">Transgene (T)</td><td colspan="2">Genotype (G)</td><td colspan="2">Planting (C)</td><td colspan="2">T * B</td><td colspan="2">T * C</td><td colspan="2">G * C</td><td colspan="2">T * G * C</td></tr><tr><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td... | <table><tr><td rowspan="2">Trait</td><td colspan="2">Transgene (T)</td><td colspan="2">Genotype (G)</td><td colspan="2">Planting (C)</td><td colspan="2">T * B</td><td colspan="2">T * C</td><td colspan="2">G * C</td><td colspan="2">T * G * C</td></tr><tr><td>df</td><td>F</td><td>df</td><td>F</td><td>df</td><td>F</td><td... | <table><tr><td rowspan="2">Trait</td><td colspan="2">Transgene (T)</td><td colspan="2">Genotype (G)</td><td colspan="2">Planting (C)</td><td colspan="2">T * B</td><td colspan="2">T * C</td><td colspan="2">G * C</td><td colspan="2">T * G * C</td></tr><tr><td>df</td><td>F</td><td>df</td><td>F</td><td>df</td><td>F</td><td... |
9ac2817057237e0d195a9990b9ff51a11795aa432fd200ac6269cef13cfc2ca2.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">African American Female</td><td colspan="2">African American Male</td><td colspan="2">Caribbean Black Female</td><td colspan="2">Caribbean Black Male</td></tr><tr><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td>... | <table><tr><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">African American Female</td><td>African American Male</td></tr><tr><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td></tr><tr><td>Ethnicity (Caribbean Black)</td><td>−0.01 *</td><td>−0.03–0.00</td><td>-</td><td>-</td><td>-</td></tr><tr><t... | <table><tr><td>African American Male</td><td colspan="2">Caribbean Black Female</td><td colspan="2">Caribbean Black Male</td></tr><tr><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td></tr><tr><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></t... |
d1879d4ef3bcfa5425a8f3fdb4db3cae5e36e76714bfcf19e59cd3da3cd35769.png | simple | <table><tr><td></td><td>Free State Department of Health ART course (Standard training)</td><td>PALSA PLUS training (Standard training)</td><td>STRETCH Training (Additional training in intervention clinics)</td></tr><tr><td>Description</td><td>Two- week training course comprising one week of lectures and one week of pra... | <table><tr><td></td><td>Free State Department of Health ART course (Standard training)</td><td>PALSA PLUS training (Standard training)</td><td>STRETCH Training (Additional training in intervention clinics)</td></tr><tr><td>Description</td><td>Two- week training course comprising one week of lectures and one week of pra... | <table><tr><td></td><td>Free State Department of Health ART course (Standard training)</td><td>PALSA PLUS training (Standard training)</td><td>STRETCH Training (Additional training in intervention clinics)</td></tr><tr><td>Mode of delivery</td><td>Lectures broadcast live from central studio with limited telephone inter... |
6bc0bb808e20820c2c5bdec338819421b54f46b46991ae58da5cd164d9d09a60.png | simple | <table><tr><td>Variable</td><td>Serum zinc μg/dl (mean+/-sd)</td><td>ZD+</td><td>ZD-</td><td>Crude OR (95% CI)</td></tr><tr><td>One-way walking distance from nearby health facility (<i>n </i>= 700)</td><td></td><td></td><td></td><td></td></tr><tr><td>0-30 min</td><td>52.5 (9.9)</td><td>311</td><td>287</td><td>0.76... | <table><tr><td>Variable</td><td>Serum zinc μg/dl (mean+/-sd)</td><td>ZD+</td><td>ZD-</td><td>Crude OR (95% CI)</td></tr><tr><td>One-way walking distance from near</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>by health facility (n = 700)</td><td></td><td></td><td></td><td></td></tr><tr><td>0-30 min</td><td>52.5 (9.9)</td><td>311</td><td>287</td><td>0.76 (0.50-1.16)</td></tr><tr><td>Longer than 30 min</td><td>51.6 (10.2)</td><td>60</td><td>42</td><td>1r</td></tr><tr><td>Frequency of ANC follow up (n = 700)</td... |
89777d8e04ef8ea170842b157e80d9d13d518ae49fe6be3c750b6362301ed31b.png | complex | <table><tr><td colspan="2"></td><td>Men (<i>n</i> = 74)</td><td>Women (<i>n</i> = 199)</td></tr><tr><td colspan="2">Age (years)</td><td>46.2 ± 14.2</td><td>46 ± 13.5</td></tr><tr><td colspan="2">BMI (kg/m<sup>2</sup>)</td><td>40.4 ± 8.3</td><td>34.8 ± 6.2</td></tr><tr><td rowspan="10">Obesity-relate... | <table><tr><td colspan="2"></td><td>Men (n = 74)</td><td>Women (n = 199)</td></tr><tr><td colspan="2">Age (years)</td><td>46.2 ± 14.2</td><td>46 ± 13.5</td></tr><tr><td colspan="2">BMI (kg/m2)</td><td>40.4 ± 8.3</td><td>34.8 ± 6.2</td></tr><tr><td rowspan="10">Obesity-related diseases (%)</td><td>Type 2 Diabetes</td><t... | <table><tr><td colspan="2"></td><td>Men (n = 74)</td><td>Women (n = 199)</td></tr><tr><td rowspan="2">ation (%)</td><td>ployed</td><td>.8</td><td>.5</td></tr><tr><td>Student</td><td>5.4</td><td>4</td></tr></table> |
e49706b7d3b8743bc912ac27e49852ad417be6f6a8693878e553476b13c82e45.png | simple | <table><tr><td>γ-rays</td><td>#</td><td>X-rays</td><td>#</td><td>UV-A</td><td>#</td><td>UV-B</td><td>#</td><td>UV-C</td><td>#</td></tr><tr><td>RAD54</td><td>30</td><td>ATLIG4</td><td>28</td><td>AT2G21970.1</td><td>2</td><td>UVH3</td><td>32</td><td>TED4</td><td>3</td></tr><tr><td>AT4G14970</td><td>30</td><td>MIM</t... | <table><tr><td>γ-rays</td><td>#</td><td>X-rays</td><td>#</td><td>UV-A</td><td>#</td><td>UV-B</td><td>#</td><td>UV-C</td><td>#</td></tr><tr><td>RAD54</td><td>30</td><td>ATLIG4</td><td>28</td><td>AT2G21970.1</td><td>2</td><td>UVH3</td><td>32</td><td>TED4</td><td>3</td></tr><tr><td>AT4G14970</td><td>30</td><td>MIM</td><td... | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>PCC1</td><td>1</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>PAD4</td><td>1</td></tr></table> |
1401d902089fc612383567335ffbf57c9ddf59743cd33e7f89ad1ddecb949225.png | complex | <table><tr><td>ROI</td><td>cluster size</td><td>peak t-value</td><td colspan="3">MNI coordinates</td><td>p-value</td></tr><tr><td></td><td></td><td></td><td>x</td><td>y</td><td>z</td><td></td></tr><tr><td>temporal pole R</td><td>12091</td><td>7.27</td><td>56</td><td>8</td><td>-38</td><td><0.001</td></tr><tr><td>para... | <table><tr><td>ROI</td><td>cluster size</td><td>peak t-value</td><td colspan="3">MNI coordinates</td><td>p-value</td></tr></table> | <table><tr><td></td><td></td><td></td><td>x</td><td>y</td><td>z</td><td></td></tr><tr><td>temporal pole R</td><td>12091</td><td>7.27</td><td>56</td><td>8</td><td>-38</td><td><0.001</td></tr><tr><td>paracentral lobule</td><td>7873</td><td>5.84</td><td>-2</td><td>-34</td><td>44</td><td><0.001</td></tr><tr><td>orbitofront... |
d60da9326915c5cf5bcdd5d1f8f54fa7d6b39499b1e9c878d01793aacefd3e42.png | complex | <table><tr><td rowspan="2">Treatment -seeking behavior for malaria</td><td>VMW village</td><td> </td><td>HC village</td><td> </td><td> </td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>p</td></tr><tr><td>Patients who sought treatment outside home*</td><td>n=110</td><td> </td><td>n=126</td><td> </td><td>0.101</t... | <table><tr><td rowspan="2">Treatment -seeking behavior for malaria</td><td>VMW village</td><td></td></tr><tr><td>n</td><td>%</td></tr><tr><td>Patients who sought treatment outside home*</td><td>n=110</td><td></td></tr><tr><td>Yes</td><td>104</td><td>94.6</td></tr><tr><td>No</td><td>6</td><td>5.5</td></tr><tr><td>Treatm... | <table><tr><td>HC village</td><td></td><td></td></tr><tr><td>n</td><td>%</td><td>p</td></tr><tr><td>n=126</td><td></td><td>0.101</td></tr><tr><td>124</td><td>98.4</td><td></td></tr><tr><td>2</td><td>1.6</td><td></td></tr><tr><td>n=124</td><td></td><td><.0001</td></tr><tr><td>0</td><td>0</td><td></td></tr><tr><td>117</t... |
0bb795af53cb959bdd01bb5b272bbbe05780bc976d9b27d98f1f5ec51ce31deb.png | complex | <table><tr><td rowspan="2"> </td><td rowspan="2">Controlsubjects</td><td colspan="3">Type 2 diabetic patients staged by neuropathy severity</td></tr><tr><td>Stage I</td><td>Stage II</td><td>Stage III</td></tr><tr><td>Corneal nerve fiber density (no/mm<sup>2</sup>)</td><td>30.6–34.1</td><td>25.6–29.4<sup><i>... | <table><tr><td rowspan="2"></td><td rowspan="2">Controlsubjects</td><td colspan="3">Type 2 diabetic patients staged by neuropathy severity</td></tr><tr><td>Stage I</td><td>Stage II</td><td>Stage III</td></tr><tr><td>Corneal nerve fiber density (no/mm2)</td><td>30.6–34.1</td><td>25.6–29.4∗</td><td>24.9–28.1†</td><td>21.... | <table><tr><td>Bead size (μm2)</td><td>7.89–8.25</td><td>9.80–10.2†</td><td>9.90–10.3†</td><td>10.0–10.4†</td></tr></table> |
1f3e2c3af6e7af5d04ddd1d1a34e47b53dec0361ef462214ad5380796aa1a04b.png | simple | <table><tr><td>Sugar</td><td>MIC</td></tr><tr><td>l-fucose</td><td>0.586 mM</td></tr><tr><td>Methyl-α,l-fucoside</td><td>0.293 mM</td></tr><tr><td>Fuc(1,2)Gal (2-O-(l-fucosyl)-d-galactose)</td><td>0.293 mM</td></tr><tr><td>Fuc(1-3)GlcNAc (3-O-(l-fucosyl)-2-N-acetyl-d-glucosamine)</td><td>0.147 mM</td></tr><tr><td>... | <table><tr><td>Sugar</td><td>MIC</td></tr><tr><td>l-fucose</td><td>0.586 mM</td></tr><tr><td>Methyl-α,l-fucoside</td><td>0.293 mM</td></tr><tr><td>Fuc(1,2)Gal (2-O-(l-fucosyl)-d-galactose)</td><td>0.293 mM</td></tr><tr><td>Fuc(1-3)GlcNAc (3-O-(l-fucosyl)-2-N-acetyl-d-glucosamine)</td><td>0.147 mM</td></tr><tr><td>Fuc(1... | <table><tr><td>Sugar</td><td>MIC</td></tr><tr><td>d-arabinose</td><td>9.375 mM</td></tr><tr><td>d-fructose</td><td>75 mM</td></tr><tr><td>d-mannose</td><td>150 mM</td></tr><tr><td>methyl-α,d-mannoside, d-glucose, d-galactose, l-arabinose, d-xylose, d-lyxose, d-tagatose, l-rhamnose</td><td>NI*</td></tr></table> |
a9e451bf094cac95ef4460f66820f737c95be809be3e4ebb5d407f76f2406753.png | simple | <table><tr><td></td><td>Range</td><td>N</td><td>Mean</td><td>SD</td><td>Response rates</td><td>Floor effects</td><td>Ceiling effects</td></tr><tr><td>EQ-5D-3 L (Utility)</td><td>−0.594 to 1</td><td>234</td><td>0.60</td><td>0.36</td><td>95.29 %</td><td>0.00 %</td><td>19.73 %</td></tr><tr><td>SF-6D (Utility)</td><t... | <table><tr><td></td><td>Range</td><td>N</td><td>Mean</td><td>SD</td><td>Response rates</td><td>Floor effects</td><td>Ceiling effects</td></tr><tr><td>EQ-5D-3 L (Utility)</td><td>−0.594 to 1</td><td>234</td><td>0.60</td><td>0.36</td><td>95.29 %</td><td>0.00 %</td><td>19.73 %</td></tr><tr><td>SF-6D (Utility)</td><td>0.34... | <table><tr><td></td><td>Range</td><td>N</td><td>Mean</td><td>SD</td><td>Response rates</td><td>Floor effects</td><td>Ceiling effects</td></tr><tr><td>SGRQ Activity Score</td><td>0 to 100</td><td>193</td><td>46.04</td><td>31.80</td><td>82.47 %</td><td>7.77 %</td><td>7.77 %</td></tr><tr><td>SGRQ Impact Score</td><td>0 to... |
79f3129236baa6b25bf0cbe19ec746e25959230b3e1256ad8ebfdbae1de6ed2d.png | complex | <table><tr><td rowspan="2">Comparison</td><td rowspan="2">Studies</td><td colspan="3">Overall effect</td><td colspan="2">Heterogeneity</td><td colspan="2">Publication bias</td></tr><tr><td>OR</td><td>Z-score</td><td><i>p</i>-value</td><td>I<sup>2</sup></td><td><i>P</i>-value</td><td>Begg's test</td><td>Egger's test</td... | <table><tr><td rowspan="2">Comparison</td><td rowspan="2">Studies</td><td colspan="3">Overall effect</td><td colspan="2">Heterogeneity</td><td colspan="2">Publication bias</td></tr><tr><td>OR</td><td>Z-score</td><td>p-value</td><td>I2</td><td>P-value</td><td>Begg's test</td><td>Egger's test</td></tr><tr><td>tt vs TT</t... | <table><tr><td>tt/Tt vs TT</td><td>36</td><td>0.89 [0.80–1.00]</td><td>1.96</td><td>0.05</td><td>56.20%</td><td>0.000</td><td>0.808</td><td>0.914</td></tr><tr><td>tt vs TT/Tt</td><td>36</td><td>0.90 [0.76–1.06]</td><td>1.29</td><td>0.197</td><td>54.20%</td><td>0.000</td><td>0.318</td><td>0.496</td></tr><tr><td>t vs T</... |
048abed8a20126a4b6cb8899b5c80f5db86cd4d696a97f3ef59035476ced6116.png | simple | <table><tr><td>HILP Group</td><td>G-A n (%)</td><td>G-B n (%)</td><td>G-C n (%)</td></tr><tr><td>Lymphocele</td><td>4 (6.6)</td><td>7 (9.4)</td><td>19 (17.5)</td></tr><tr><td>Bleeding necessitating surgery</td><td>-</td><td>1(1.3)</td><td>3(2.7)</td></tr><tr><td>Deep venous thrombosis</td><td>-</td><td>2(2.6)</td><td>3... | <table><tr><td>HILP Group</td><td>G-A n (%)</td><td>G-B n (%)</td><td>G-C n (%)</td></tr><tr><td>Lymphocele</td><td>4 (6.6)</td><td>7 (9.4)</td><td>19 (17.5)</td></tr><tr><td>Bleeding necessitating surgery</td><td>-</td><td>1(1.3)</td><td>3(2.7)</td></tr><tr><td>Deep venous thrombosis</td><td>-</td><td>2(2.6)</td><td>3... | <table><tr><td>HILP Group</td><td>G-A n (%)</td><td>G-B n (%)</td><td>G-C n (%)</td></tr><tr><td>Pulmonary microembolism</td><td>-</td><td>1(1.3)</td><td>-</td></tr><tr><td>Death (MOF or ARDS)</td><td>-</td><td>1(1.3)</td><td>2(1,8)</td></tr></table> |
93365acfc78cd4d494ac9a8c121df8f5e5016ac1472783452cf4fded39b04766.png | complex | <table><tr><td>Schematic Name</td><td>Arabidopsis homologue CloneID</td><td>Normalized Expression Levels</td><td>Description</td><td>KEGGID</td></tr><tr><td colspan="4">Glycolysis - KEGG PATHWAY</td><td> </td></tr><tr><td>contig 763</td><td>At3g04120</td><td>4.1</td><td>Glyceraldehyde 3-phosphate dehydrogenase, cytosol... | <table><tr><td>Schematic Name</td></tr><tr><td>Glycolysis - KEGG PATHWAY</td></tr><tr><td>contig 763</td></tr><tr><td>contig 251</td></tr><tr><td>contig 30</td></tr><tr><td>contig 1110</td></tr><tr><td>contig 3191</td></tr><tr><td>contig 441</td></tr><tr><td>Cysteine and Methionine Metabolism</td></tr><tr><td>contig 31... | <table><tr><td>Arabidopsis homologue CloneID</td><td>Normalized Expression Levels</td><td>Description</td><td>KEGGID</td></tr><tr><td colspan="3">Glycolysis - KEGG PATHWAY</td><td></td></tr><tr><td>At3g04120</td><td>4.1</td><td>Glyceraldehyde 3-phosphate dehydrogenase, cytosolic</td><td>Ac763</td></tr><tr><td>At4g33070... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.